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FOREWORD

Bernard J. Perey, M.D., M.Sc., F.R.C.S.[C]

This issue of the Journal represents a de
parture from the usual format. It is meant to
reflect changes in the editorial policy which
has now become the responsibility of the
Royal College of Physicians and Surgeons
of Canada. The overall objective of the
College is to make the Journal responsive
to the needs of its membership, not only in
providing potential contributors with a
suitable forum of expression but, also, in
supplying a practical tool of continuing
education. It is within the framework of the
latter goal that the present issue constitutes
a modest Canadian experiment in medical
communication. For this reason, it is hoped
that the membership will actively respond
with comments, criticism and suggestions
which will guide the College in its efforts.
The scientific material presented here has
been chosen from the edited transcripts of a
postgraduate course on intestinal and ano
rectal diseases held in Sherbrooke, Que., on
May 2, 3 and 4, 1974. This course was
initiated and sponsored by the Royal Col
lege of Physicians and Surgeons of Canada
and was jointly organized by the depart
ments of General Surgery and Continuing
Medical Education of the University of

Sherbrooke, under the expert direction of
Drs. G. Devroede and R. Dufresne. The
following presentations pertain essentially to
three selected clinical conditions and repre
sent about one-quarter of the actual course
which dealt excellently with many other
aspects of intestinal and anorectal diseases.
One feature of this issue is a short selfassessment program prepared under the di
rection of Dr. Ls-P. Lejeune. Its aim is to
provide the reader with a rapid appraisal
of his depth of knowledge of the subject and
to allow him to improve his performance by
reading the rest of the issue. Readers in
terested in more extensive information may
use the selected references. Indeed, the avail
able literature on the physiology and patho
logy of the intestine has reached staggering
proportions. During the first six months of
this year, 2,500 publications appeared on
the subject and about 100 papers conti
nue to appear every week. If we consider
that each author who develops new infor
mation immediately increases the compa
rative ignorance of the rest of the world by
the same amount, we have to agree with the
President of the Royal College, Doctor K.
J. R. Wightman, that the current “ignorance
explosion” is more frightening than the
“knowledge explosion”. Obviously the
greatest challenge is not in finding new
knowledge but in transmitting selected
practical information to the practitioner at
the bedside.
The faculty participating in this course is
to be thanked for the excellence of its con
tribution and for its ready co-operation.
I also wish to express particular thanks to
Dr. George Konok who has chaired our
publication committee and has carried out
most of the required editing.
Finally, it is my pleasure to report that
the expertise and dedication offered by
C.M.A. Publications is a good indication of
the expected success of the joint venture
undertaken by the Canadian Medical As
sociation and the Royal College.
BERNARD J . F. PEREV, M.D.,

Guest Editor,
Centre Hospitalier Universitaire.
Sherbrooke, Que.
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AVANT-PROPOS

Le format different de ce numero du
Journal vise a refleter la nouvelle orienta
tion de sa politique editoriale qui est maintenant entre les mains du College Royal
des Medecins et Chirurgiens du Canada.
L’objectif ultime du College est de mettre
le Journal au service de ses membres, non
seulement en leur offrant un moyen d’expression, mais aussi en leur apportant un
outil pratique d’enseignement continu. C’est
dans le cadre de ce dernier but que ce nu
mero constitue une modeste experience
canadienne en communication medicale. Le
College espere done que ses membres exprimeront leurs commentaires et suggestions
afin de Fassister dans sa tache.
Les presentations scientifiques qui apparaissent ici, ont ete extraites des enregistrements sur bande magnetique d’un cours de
perfectionnement sur les maladies intestinales et ano-rectales qui a eu lieu a Sher
brooke, Que., les 2, 3 et 4 mai 1974. Ce
cours avait ete organise sous l’egide du
College Royal par les departements de chirurgie generate et d’enseignement medical
continu de l’Universite de Sherbrooke, sous
l’experte direction des docteurs G. Devroede
et R. Dufresne. En vue des restrictions d’espace, il n’a malheureusement ete possible
de publier que la partie du cours qui portait
sur trois maladies intestinales. Ceci cons
titue a peu pres un quart du cours entier.
On trouvera ci-apres un exercice d’autoevaluation prepare sous la direction du docteur Ls-P. Lejeune. Le but de ce test est
de permettre au lecteur d’evaluer rapidement l’etendue de ses propres connaissances
du sujet traite. Apres avoir lu le texte, le
lecteur peut aussi reprendre le test et deter
miner Fefficacite de son etude. Une biblio
graphic a ete preparee a l’intention de ceux

qui desirent obtenir de Finformation additionnelle. Ces references ont ete choisies au
sein d’une litterature volumineuse. Lors des
six premiers mois de cette annee, a peu
pres 2,500 travaux ont ete publies sur la
physiologie et la pathologie de l’intestin, et
une centaine de manuscripts continuent a
paraitre chaque semaine. Si l’on considere
que chaque auteur qui apporte une donnee
nouvelle augmente immediatement d’autant
Fignorance de tout le monde, il faut accep
ter la constatation du president du College
Royal, le docteur K. J. R. Wightman, que
Fexplosion actuelle de Fignorance est plus
menagante que Fexplosion des connaissan
ces. De toute evidence, le plus grand defi
auquel notre profession doit maintenant
faire face n’est pas tellement l’avancement
de la science mais plutot la transmission de
Finformation utile disponible au consommateur qu’est le medecin clinicien.
Les professeurs ayant participe a ce
cours de perfectionnement meritent nos fe
licitations pour Fexcellence de leur contri
bution, ainsi que pour leur genereuse col
laboration.
Je desire remercier tout particulierement
le docteur George Konok qui a dirige notre
Comite de redaction et qui a rendu cette
publication possible par Fardeur et la qualite de son travail.
Enfin, j’ai eu le plaisir de constater que
Fexpertise et le devouement du personnel
de “C.M.A. Publications”, est un indice
encourageant du succes qu’il faut attendre
du projet entrepris conjointement par l’Association Medicale Canadienne et le Col
lege Royal.
Bernard J. F. P erey, m .d.,
editeur invite,
Centre Hospitalier Universitaire,
Sherbrooke, Que.
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A SELF-ASSESSMENT TEST

EVALUEZ VOS CONNAISSANCES
DES MALADIES INFLAMMATOIRES
DE LTNTESTIN:
EXERCICE D’AUTO-EVALUATION

Ls-P. LEJEUNE and B. J. PEREY

Ls-P. LEJEUNE and B. J. PEREY

To the following multiple-choice questions
the answer is

D ans les questions a choix de reponse suivantes un ou plusieurs enonces peut (ou
peuvent) etre correct(s).

TEST YOUR KNOWLEDGE OF
INFLAMMATORY BOWEL DISEASES:

A
B
C
D
E

if 1, 2, 3 are correct
if 1, 3
are correct
if 2, 4 are correct
if 4 only is correct
if 1, 2, 3, 4 are correct

A
B
C
D
E

lorsque
lorsque
lorsque
lorsque
lorsque

1, 2, 3, sont corrects
1, 3 sont corrects
2, 4 sont corrects
4 seulement est correct
1, 2, 3, 4 sont corrects

(1) The theory that Crohn’s disease is due
to a micro-organism is supported by the
fact(s) that:

(1) L’hypothese que la maladie de Crohn
est causee par un microorganisme est appuyee par le(s) fait(s) que:

1. bacteria can be cultured from diseased
tissue
2. salicylazosulfapyridine (Salazopyrin) is ef
fective against the disease
3. azathioprine (Imuran) is effective against
the disease
4. the disease can be transmitted to laboratory
animals by injecting a filtrate of diseased
tissue.

1. l’on peut faire croitre des bacteries a partir
de tissu affecte
2. la salicylazosulfapyridine (Salazopyrin) est
efficace dans cette maladie
3. l’azathioprine (Imuran) est efficace dans
cette maladie
4. Ton peut transmettre la maladie a des animaux de laboratoire en injectant un filtrat
de tissu affecte.

(2) The incidence of Crohn’s disease is in
creased :

(2) On retrouve une incidence plus elevee
de maladie de Crohn:

1. between the ages of 20 and 40, and between
the ages of 50 and 70
2. in the Southern hemisphere
3. among relatives of patients suffering from
the disease
4. in the male.

1. entre l’age de 20 et 40 ans et entre l’age
de 50 a 70 ans
2. dans l’hemisphere Sud
3. dans la parente des malades souffrant de
cette maladie
4. chez le male.

(3) Patients suffering from regional ileitis
have a tendency to develop:

(3) Les malades atteints d’enterite regionale
ont tendance a presenter:

1. an iron deficiency anemia which responds
poorly to the ingestion of iron
2. a low total iron-binding capacity
4. cholelithiasis.

1. une anemie ferriprive resistante a l’ingestion de fer
2. une diminution de la capacite de fixation
du fer
3. une deficience en vitamine B12
4. une incidence de cholelithiase augmentee.

(4) The endoscopic features of Crohn’s
disease of the rectum include:

(4) Parmi les signes endoscopiques de la
maladie de Crohn du rectum on retrouve:

1. linear ulcerations
2. the persistence of a normal vascular pattern
between the lesions
3. the presence of localized rather than dif
fuse lesions
4. punched out ulcers.

1. des ulcerations lineaires
2. la preservation d’un reseau vasculaire d’apparence normale entre les lesions
3. le caractere localise plutot que diffus des
lesions
4. des ulceres a l’emporte-piece.

3. vitamin Bi2 insufficiency
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(5) Complications of Crohn’s disease in
clude :

(5) Parmi les complications de la maladie
de Crohn on retrouve:

1.
2.
3.
4.

1.
2.
3.
4.

ankylosing spondylitis
uveitis
pyoderma gangrenosum
cancer of the large bowel.

(6) Acceptable
disease include:

operations

for

la spondylite ankylosante
l’uveite
la pyodermite gangreneuse
le cancer du colon.

Crohn’s

(6) Parmi les operations acceptables utilisees dans la maladie de Crohn, on retrouve:

1. routine division, during each operation,
of all adhesions in order to assess fully the
extent of the disease

1. la dissection systematique, pendant chaque
intervention, de toutes les brides adherentielles presentes afin de preciser l’etendue
de la pathologie
2. la simple suture du duodenum lorsqu’une
atteinte secondaire provenant d’une anse
intestinale adjacente entraine la resection
d’une petite portion de la paroi de cet
organe
3. l’appendicectomie lorsque l’appendice est
atteint
4. la proctocolectomie totale.

2. simple closure of the defect in the duo
denal wall when secondary involvement
from adjacent bowel has required limited
resection of the duodenum
3. appendectomy when the appendix is in
volved
4. total proctocolectomy.
(7) A bypass operation is usually the opera
tion of choice for regional ileitis when:

(7) La derivation intestinale est habituellement l’operation de choix dans l’ileite terminale lorsque:

1. the patient is receiving corticosteroids
2. there is a posterior perforation with a re
troperitoneal inflammatory mass
3. the patient is over 60 years of age
4. there is bowel obstruction but the disease
is inactive.

1. le malade regoit des corticosteroi'des
2. il y a perforation posterieure avec une
masse inflammatoire retroperitoneale
3. le malade a plus de 60 ans
4. il y a occlusion intestinale mais la maladie
est inactive.

(8) Histological features suggestive of re
gional enteritis include:

(8) Parmi les caracteristiques histopathologiques qui suggerent le diagnostic d’enterite
regionale on retrouve:

1. granulomatous lesions
2. a noticeably thickened and abnormal sub
mucosa
3. vertical mucosal fissures
4. the presence of healthy mucosa between
ulcers.

1. des granulomes
2. une sous-muqueuse nettement epaissie et
anormale
3. des fissures verticales de la muqueuse
4. la presence de muqueuse normale entre les
ulcerations.

(9) Following intestinal resection for Crohn’s
disease, the risk of recurrence is increased:

(9) Apres une resection intestinale pour
maladie de Crohn, le risque de recidive est
augmente :

1. when the disease originally involved the
small rather than the large bowel
2. when the disease was of short duration at
the time of surgery
3. in the young
4. in the male.

1. si la maladie interessait l’intestin greie plutot que le colon
2. si la maladie etait de courte duree au mo
ment de l’intervention
3. chez un individu jeune
4. chez le male.
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(10) In patients suffering from ulcerative
colitis, acute toxic dilatation of the colon
may be precipitated by:
1. anticholinergic drugs
2. opiates
3. hypokalemia
4. a barium enema.

(10) Chez les malades atteints de rectocolite
hemorragique, la dilatation aigue toxique
du colon peut etre precipitee par:
1. les anticholinergiques
2. les opiaces
3. l’hypokaliemie
4. un lavement baryte.

(11) In ulcerative colitis the risk of cancer
of the large bowel is increased:
1. when the disease has been active for more
than 10 years
2. when corticosteroids have been used
3. when the entire colon is involved
4. in young adults.

(11) Dans la rectocolite hemorragique, la
degenerescence maligne est plus frequente:
1. lorsque la maladie evolue depuis plus de
10 ans
2. lorsque les corticosteroi'des ont ete utilises
3. lorsque tout le colon est atteint
4. chez l’adulte jeune.

(12) Acute toxic megacolon is known to oc
cur in:
1. ischemic colitis
2. Crohn’s disease
3. diverticulitis
4. ulcerative colitis.

(12)
peut
1. la
2. la
3. la
4. la

(13) The typical histological features of
ulcerative colitis include:

2. the involvement of all layers of the bowel
wall
3. the presence of normal mucosa between
affected areas
4. destruction of the mucosal crypts.

(13) Parmi les caracteristiques histopathologiques typiques de la rectocolite hemor
ragique, on retrouve:
1. la presence de fissures verticales de la
muqueuse
2. l’atteinte de toutes les couches de la paroi
du colon
3. la presence de muqueuse normale entre
les zones atteintes
4. la destruction des cryptes de la muqueuse.

(14) Complications of ulcerative colitis in
clude :
1. sclerosing cholangitis
2. cirrhosis of the liver
3. arthritis
4. thyroiditis.

(14) Parm i les complications de la rectoco
lite hemorragique, on retrouve:
1. la cholangite sclerosante
2. la cirrhose du foie
3. l’arthrite
4. la thyroi'dite.

(15) The drugs usually considered ap
propriate in the treatment of moderately
severe ulcerative colitis limited to the rec
tum and rectosigmoid colon include:

(15) Parm i les formes de therapeutique medicale habituellement utilisees dans le traitement des rectocolites hemorragiques de
severite moderee et limitees au rectum et
rectosigmoi'de, on retrouve:
1. les lavements de cortico'ides
2. les cortico'ides par voie buccale
3. la salicylazosulfapyridine (Salazopyrin)
4. l’ACTH.

1. the presence of vertical mucosal fissures

1.
2.
3.
4.

corticosteroid enemas
systemic corticosteroids
salicylazosulfapyridine (Salazopyrin)
ACTH.

(16) W hen using corticosteroid enemas for
ulcerative colitis it is advisable:
1. to introduce the enema cannula as far as
the upper limit of the disease
2. to watch for the development of leuko
penia

La dilatation aigue toxique du colon
survenir dans:
colite ischemique
maladie de Crohn
diverticulite aigue
rectocolite hemorragique.

(16) Lorsque les lavements de corticoides
sont utilises dans le traitement de la recto
colite hemorragique, il est recommande:
1. d’introduire la canule de lavement jusqu’a
la limite de la pathologie
2. de surveiller l’apparition d’une leucopenie
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3. to use always at least 300 ml of enema
4. to verify the level reached by the enema
by use of contrast material.
(17) Endoscopic signs of ulcerative colitis
include:
1. disappearance of the normal vascular pat
tern
2. edema of the mucosa
3. contact bleeding
4. involvement limited to part of the circum
ference of the bowel.
(18) It has been observed that when women
suffering from ulcerative colitis or Crohn’s
disease become pregnant:
1. ulcerative colitis does not endanger the
fetus
2. ulcerative colitis tends to undergo a flareup during the postpartum period
3. Crohn’s disease tends to cause stillbirths
4. Crohn’s disease may improve or worsen.
(19) Acute ischemic colitis:
1. may be ruled out when arteriography
shows patency of the mesenteric arteries
and their major branches
2. must be treated surgically
3. is most common in the ascending colon
4. tends to produce a radiological feature
known as “thumbprinting”.

367

3. de toujours utiliser plus de 300 ml de la
vement
4. de verifier le niveau atteint par le lave
ment en y ajoutant un peu de baryte.
(17) Parmi les signes endoscopiques de la
rectocolite hemorragique il faut inclure:
1. la disparition du reseau vasculaire normal
2. l’oedeme de la muqueuse
3. le saignement facile au contact
4. l’atteinte limitee a une partie de la circonference de l’intestin.
(18) Au sujet de la grossesse chez les fem
mes atteintes de rectocolite hemorragique
ou de maladie de Crohn l’on peut dire que:
1. la rectocolite hemorragique ne presente pas
de danger pour le foetus
2. la rectocolite hemorragique a tendance a
s’exacerber pendant la periode post-partum
3. la maladie de Crohn a tendance a conduire a l’accouchement d’enfants mort-nes
4. la maladie de Crohn peut s’ameliorer ou
s’exacerber au cours de la grossesse.
(19) La colite ischemique aigue:
1. peut etre exclue lorsque l’arteriographie
demontre la permeabilite des arteres mesenteriques et de leurs branches principales
2. doit etre traitee par intervention chirurgicale
3. est plus f Aquente dans le colon ascendant
4. a tendance a produire une image radiologique d’empreintes de doigts (“thumbprint
ing”).

In the following multiple choice questions,
the single best answer is to be identified.

Dans les questions a choix de reponses suivantes il s’agit d’identifier la reponse la plus
appropriee. Un seul enonce est correct.

(20) In Crohn’s disease, dramatic remis
sions are usually observed with the use of:

E. none of the above.

(20) Dans la maladie de Crohn, des remis
sions impressionnantes sont habituellement
obtenues avec:
A. la salicylazosulfapyridine (Salazopyrin)
B. les corticoi'des
C. l’azathioprine (Imuran)
D. la gamma globuline provenant de malades
en periode de remission
E. aucun des medicaments nommes ci-dessus.

(21) The upper normal limit of the diame
ter of the transverse colon, as measured on
plain films, is:
A. 5.5 cm
B. 6.5 cm
C. 7.5 cm
D. 8.5 cm
E. 9.5 cm.

(21) La limite superieure du diametre du
colon transverse normal, tel que mesure
sur une plaque simple de l’abdomen est de:
A. 5.5 cm
B. 6.5 cm
C. 7.5 cm
D. 8.5 cm
E. 9.5 cm.

A.
B.
C.
D.

salicylazosulfapyridine (Salazopyrin)
corticosteroids
azathioprine (Imuran)
gamma globulin from patients in remission

THE CANADIAN JOURNAL OF SURGERY

368

Vol. 17

(22) In acute toxic megacolon, colonic dis
tension is usually most prominent in:

(22) Dans la dilatation aigue toxique du
colon, la distention est habituellement plus
evidente au niveau:

A.
B.
C.
D.
E.

A.
B.
C.
D.
E.

the
the
the
the
the

cecum
ascending colon
transverse colon
descending colon
sigmoid colon.

du
du
du
du
du

caecum
colon ascendant
colon transverse
colon descendant
colon sigmoi'de.

(23) When acute mesenteric artery occlu
sion produces severe intestinal ischemia,
necrosis begins:

(23) Lorsque l’occlusion d’une artere mesenterique conduit a une ischemie intestinale severe, la necrose se produit initialement:

A.
B.
C.
D.
E.

A.
B.
C.
D.
E.

in
in
in
in
in

the mucosa
the submucosa
the muscularis
the serosa
all layers simultaneously.

dans
dans
dans
dans
dans

la muqueuse
la sous-muqueuse
la couche musculaire
la sereuse
toutes les couches simultanement.

(24) When acute occlusion of the superior
mesenteric artery produces severe intestinal
ischemia, the patient usually develops im
mediately:

(24) Lorsque l’occlusion aigue de l’artere
mesenterique superieure produit une ische
mie intestinale severe, la malade habituel
lement demontre immediatement:

A.
B.
C.
D.
E.

A.
B.
C.
D.
E.

severe abdominal distension
severe vomiting
massive gastrointestinal bleeding
a rigid abdominal wall
none of the above.

K ey TO

the

Correct A nsw ers

un meteorisme abdominal severe
des vomissements abondants
une hemorragie digestive massive
une paroi abdominale rigide
aucun des signes enonces ci-dessus.

C lef

d es

R e p o n s e s E x a c tes

(1) D

(5) E

(9) A

(1 3 ) D

(1 7 ) A

(21) A

(2) B

(6) D

(10) E

(1 4 ) A

(1 8 ) E

(22) C

(3) E

(7) C

(11) B

(1 5 ) B

(1 9 ) D

(23) A

(4) E

(8) E

(12) C

(1 6 ) D

(2 0 ) E

(24) E
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DIFFERENTIAL DIAGNOSIS OF COLITIS
G. J. DEVROEDE
F our hundred years BC, Hippocrates knew

that diarrhea was not due to a single dis
ease. During the Middle Ages it became
known that dysentery affected the less wellto-do during the summer months while the
bloody flux described in 1666 by Syden
ham was found in all classes of society. In
1859 Sir Samuel Wilks described “the mor
bid appearance of the intestine of Miss
Banks” and coined the phrase “ulcerative
colitis”. Only very recently has Crohn’s dis
ease been distinguished from ulcerative co
litis. Other types of colitis have been de
scribed and the differential diagnosis of
colitis has become a complex problem (Ta
ble I).
The problem is encountered even in the
TABLE

gathering of data. For instance, there is
poor observer agreement in the interpreta
tion of anemia, dehydration, abdominal
guarding and rigidity. Even pathological
examination has its limitations. For example,
in Crohn’s disease of the rectum a single
biopsy will indicate the diagnosis in only
about 10% of cases while the accuracy can
increase to 60% if several biopsies are ex
amined.
The presence of abdominal pain favours
the diagnosis of Crohn’s disease rather than
ulcerative colitis and the presence of an
abdominal mass suggests diverticular or
Crohn’s disease. Rectal bleeding is not
present in all forms of colitis (Table II).
Patients with Crohn’s disease frequently
I.—C olitis
Unknown etiology

Known etiology

Crohn’s disease
Ulcerative colitis
Pseudomembranous colitis
Necrotizing colitis

Diverticulitis
Ischemic colitis and arteritis
Radiation colitis
Uremic colitis
Infections:

staphylococcal enteritis
bacillary dysentery (shigellosis)
gonorrheal proctitis
tuberculosis of the colon
lymphogranuloma venereum (Nicolas-Favre)
histoplasmosis

Parasitic diseases:

amebic colitis
schistosomiasis
balantidiasis

Conditions caused by antibiotics:

lincomycin colitis
clindamycin colitis

TABLE II.—D ifferential D iagnosis
Bloody diarrhea
Ulcerative colitis
Ischemic colitis
Radiation proctitis
Infections:
shigellosis (bacillary dysentery)
lymphogranuloma venereum
Parasitic
diseases (acute).'amebic colitis
schistosomiasis

of

C olitis
Bloodless diarrhea
Crohn’s disease
Uremic colitis
Pseudomembranous colitis
Infections:
staphylococcal enteritis
tuberculosis
histoplasmosis
Parasitic diseases (chronic):
amebic colitis
schistosomiasis
balantidiasis
Diverticular disease
Lincomycin colitis
Clindamycin colitis
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have anal fissures, fistulas and abscesses, caused by Crohn’s disease but may also
indolent multiple ulcers of the perineum and be found in ischemic (Fig. la) and amebic
a marked tendency to develop fistulas.
(Fig. lb) colitis as well as in other condi
In colitis, stool cultures and search for tions.
parasites, endoscopy, mucosal biopsies, ra
The appearance of the mucosa is also
diographic studies of the small and large helpful. A healed granular mucosa is the
bowel, and skin and serological tests should only specific sign of ulcerative colitis. The
always be done. Occasionally arteriograms absence of a vascular pattern with increas
and, in acute situations, plain films of the ing mucosal fragility is very common in co
abdomen will be useful.
litis, but in ulcerative colitis the lesions are
Endoscopy is a major diagnostic measure diffuse and extend to the dentate line, spar
that will be the object of detailed discussion ing no area. In contrast to Crohn’s disease,
during this course. It is important to note ulcerative colitis is strictly a mucosal dis
whether the lesions are diffuse or some ease. Acute pseudomembranous colitis is
areas of the mucosa remain normal. The easy to recognize (Fig. lc). The pseudo
presence of lesions beyond a normal rectum membranes are yellow and surrounded by a
is also an important clue to diagnosis. His fiery red mucosa. They are attached to the
tological studies of biopsies are specific for mucosa and leave a small ulcer when re
some parasites, pseudomembranous colitis, moved. At biopsy (frozen sections are rec
tuberculosis and histoplasmosis, and they ommended for rapid diagnosis) a pseudo
are useful in the diagnosis of vascular prob membrane is found attached to the mucosa,
lems, uremic colitis and Crohn’s disease.
with dilatation of the glands underneath.
Recognition of the type of ulcer is useful. After treatment the appearance of the bowel
Discrete, localized ulcers of the rectum and may become indistinguishable from that of
sigmoid, in our experience, are usually ulcerative colitis, but ultimately it will return

Fig. 1.—(a) Ischemic colitis in a patient with severe arteriosclerosis and carbon monoxide poisoning.
The lesions disappeared as the patient recovered from his intoxication, (b) Amebic colitis, (c) Typical
pseudomembranous colitis, (d) Actinic proctitis, (e) Telangiectasias in a patient with schistosomiasis,
(f) Uremic colitis. Note the edema and intramucosal hemorrhage. (Published by courtesy of the Olym
pus Corporation of Canada, G. D. Searle & Co. of Canada Ltd. and the ACMI Company.)
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to normal. The appearance of the vascular
pattern can be an im portant' diagnostic
feature. Telangiectasias surround the ulcer
of actinic proctitis (Fig. Id). Dilated capil
laries were found in another patient who
was infested by Schistosoma mansoni (Fig.
le). The egg of this parasite has a hooklet
on the side which is very well seen in fresh
specimens (Fig. 2). Edema of the mucosa in
a fixed, narrowed, sacculated bowel is
characteristic of diverticulitis. Occasionally
diverticula— and, very seldom, bleeding
from one of them— may be seen. Edema
and capillary extravasation are also- seen in
patients with uremic colitis (Fig. ’If). These
lesions regress with improvement of uremia.
Plain radiographs of the abdomen are
useful to evaluate the size and shape of
the colon. The upper limit of the diameter
of the normal transverse colon is 5.5 cm
and when it exceeds this, in the absence of
mechanical obstruction, toxic dilatation
should be the diagnosis. This finding may
occur in diseases other than ulcerative colitis
and we have seen it in ischemic colitis,
Crohn’s disease, and pseudomembranous
colitis. In the latter disease, thickening of
the mucosal folds of the transverse colon
may also be clearly seen on the plain film.
The diagnostic criteria as detected by the
barium enema are almost the same as those
seen at endoscopy. Are the lesions diffuse
or discrete? Are they distal or proximal?
Barium enema is greatly superior to en
doscopy in the estimation of ulcer depth

Fig. 2.—Egg of Schistosoma mansoni showing
hooklet.
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and the identification of fistulas and diver
ticula. Discrete ulcers, solitary or multiple,
and skip areas are typical of Crohn’s disease
and fistulas are frequently seen in this con
dition. Thumbprinting, which is typical of
ischemic colitis, may also be seen in pseu
domembranous colitis and Crohn’s disease.
Radiology may be misleading in ulcerative
colitis characterized by diffuse superficial
microulcerations, as colonoscopy may show
disease in areas of the colon that are radiologically normal (Fig. 3). For this reason
we now do routine colonoscopy and take
multiple biopsies in these cases. The presence
of an abdominal mass associated with left
lower quadrant pain and sigmoid spasm as
found on barium enema is not sufficient
evidence for the diagnosis of diverticulitis.
Diverticulitis is in fact peridiverticulitis sec
ondary to the penetration of colonic bac
teria through a ruptured diverticulum.
Rather, such a diagnosis requires clinical
evidence of peritonitis or fistula or else ra
diological evidence of extramucosal com
pression or fistula. Arteriograms may be
useful in the diagnosis of ischemic colitis.
Intravenous pyelograms and small bowel

Fig. 3.—Total colitis unrecognized on a stand
ard barium enema. The radiological diagnosis was
left-sided colitis, but biopsies obtained during
colonoscopy were positive all the way to the
cecum.
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studies are often useful in the differential
diagnosis of colitis by their demonstration
of extracolonic lesions. I shall leave the
detailed discussion of x-ray findings in co
litis to the radiologists.
The follow-up of patients with colitis is
important as it may yield diagnostic clues.
The main difficulties lie in distinguishing
Crohn’s disease from ulcerative colitis. This
distinction is not purely academic. For in
stance, in total ulcerative colitis the risk of
cancer is 20% after 20 years. By contrast
it is only 2.8% after 20 years for Crohn’s

Vol. 17

disease of the colon, a risk of more modest
magnitude. Similarly, 20% of patients with
total ulcerative colitis die within a period
of 10 years, while this is true of only 10%
of patients with Crohn’s disease.
In summary, characteristic lesions may
be recognized by a systematic use of all
available diagnostic techniques. One or an
other may provide a definitive clue. In all
the other cases one should make the diag
nosis that is most likely on the basis of all
available data, subject to periodic recon
sideration.

DISCRIMINANT AND BAYES ANALYSIS IN THE
DIFFERENTIAL DIAGNOSIS OF COLITIS
JOHN E. LENNARD-JONES

L ewis C arroll , the author of “Alice in
Wonderland”, was a mathematician. Now
I, too, will lead you into an Alice-in-Wonderland type of world of differential diag
nosis. It is a mathematical game, and I hope
you will find it enjoyable. I think, however,
that it does have important practical mes
sages for us. What we are concerned with
is how to define a disease.
A disease can be described as monothetic
if we can define it by a single characteristic.
If that characteristic is present, then the
disease is present; if that characteristic is
absent, then the disease is absent. One may
have an enzyme defect like phenylketonuria
or an infection like tuberculosis. But one
must not forget that tuberculosis may affect
different organs in the body, with widely
varying manifestations, yet one can define
it because Mycobacterium tuberculosis is
present in the lesion. One may also define
a disease anatomically, like polycystic dis
ease of the kidney, or physiologically, like
glaucoma.
Many of the diseases we have to deal
with in gastroenterology do not have such
a single defining characteristic, and there
fore they properly belong to the group of
diseases described as polythetic. As Dr.
Devroede has pointed out, there are serious
difficulties in properly classifying chronic

non-specific colonic inflammatory disease.
Therefore we thought that it would be in
teresting to apply some mathematical meth
ods of classification to inflammatory bowel
disease.
How can we classify diseases? The old
and well-established method is to take a
large group of patients and look for com
mon features. This is what we usually do
and the medical literature is full of ex
amples. It is, however, possible to classify
diseases in an entirely different way. Let us
suppose that one takes a number of dif
ferent patients and looks at a number of
clinical features. If one finds that certain
patients have similar features, then one can
group them together. This technique has
been used quite widely in biology for clas
sifying animals; it has been used in archeol
ogy to classify the age of coins. For this
type of analysis it is essential to collect a
lot of well-defined data. A computer with
out any preconceived notions then looks at
the data to see if they can be divided into
clusters. Now, supposing that one can div
ide one’s patients into groups by this method
or by any other method, then one can anal
yze the data further to find the smallest
number of distinguishing features that will
separate the patients into clusters. In med
ical taxonomy we try to find the smallest
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number of attributes we can use to dis
tinguish between diseases.
In order to apply medical taxonomy to
inflammatory bowel disease we took a total
of 156 clinical features. Before we started
we designed definitions for the various
symptoms and signs and tested them in a
pilot series of patients. Having defined suit
able criteria, we put them into a form
which could be coded and fed into a com
puter. Forty-seven of the indicants were
derived from surgical specimens and were
not available for every patient. The remain
ing 109 attributes were derived from the
clinical history and examination, hematol
ogical and biochemical findings, radiographs
and histological appearances of rectal biop
sies.
Information was collected from 109 con
secutive patients with inflammatory bowel
disease admitted to St. Mark’s Hospital,
London, England. The computer divided
the patients into a series of groups, each
known as a cluster (Fig. 1). The number
in the centre of the circle is the number
of patients in that cluster. You notice a
cluster that contains 45 patients and, close
to it, but not actually fitted within the clus
ter, there are 25 more patients, technically
known as satellites. There are a number of
small clusters with six, two, two, two, five
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and two patients respectively, and some
patients who are satellites of these clusters.
The computer was unable to place eight
patients in any cluster. Having reached this
stage we thought it would be interesting to
correlate these clusters, derived without
preconceptions about the clinical diagnosis,
with the diagnostic label that we had at
tached to these patients. Speaking gener
ally we found that the 45 patients in the
large cluster and 22 of its satellites corre
sponded very closely to the condition we
call proctocolitis, or ulcerative colitis. The
patients on the right side, in the multitude
of small clusters, corresponded to what we
call Crohn’s disease of the colon. What
can we learn from all this? First of all, we
find that the disease we call ulcerative colitis
is a rather uniform disease. On the other
hand, we also notice that the patients with
what we currently call Crohn’s disease form
a very heterogeneous collection and, of
course, are much more difficult to define.
It is interesting to speculate whether or not
there may be more than one disease here.
We tend to talk about Crohn’s disease in
a rather broad way, but we must remember
that all we have done, in fact, is to put a
label on a group of patients and there may
be a number of distinct diseases in the
group.
But let us look at the data in another
way. I have said that if you can divide pa
tients into groups, then you can find out by
mathematical techniques the smallest num
ber of attributes that will separate those
patients into these groups. We took 97 pa
tients whom we had separated, according
to the sort of clinical criteria discussed by
Dr. Devroede, into 61 patients with ulcer
ative colitis and 36 patients with Crohn’s
disease (Table I). In this case we studied
TABLE I.- - P attern Analysis of 97 P atients
with U lcerative C olitis or C rohn ’s D isease

8 unplaced

12
satellites

Fig. 1.—Cluster analysis of 109 patients with
inflammatory bowel disease. (Reproduced from
J ones JH, L ennard-Jones JE, M orson BC, et
al: Numerical taxonomy and discriminant
analysis applied to non-specific colitis. Q Med J
42: 715. 1973.)

A ttrib u te

G rade

Anal canal............

1. 2

)

Vascular pattern

1. 2. 3

Inflammation. . .

1. 2. 3

)
) 36 patterns
) e.g. 2.1.3.2 etc.

Granulomas..........

1. 2

)
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anal canal on digital examination; they had
a completely absent vascular pattern on
sigmoidoscopy; they had diffuse inflamma
tion on biopsy; they had no granuloma on
biopsy. There were some other patterns, but
there was only one pattern that over
lapped with the patients who had Crohn’s
disease. This again shows that ulcerative
colitis is a homogeneous disease. There are
only five patterns in 61 patients, and one
pattern is found in 57 of them. In Crohn’s
colitis, on the other hand, 36 patients
formed 16 patterns. (If I put these data on
a figure it would be difficult to comprehend
at a glance.) Again, we find that in fact
Crohn’s colitis is quite a heterogeneous
disease. There is only one pattern shared
between the two groups of patients with
ulcerative colitis and Crohn’s disease.
From our discriminant analysis we find
that in ulcerative colitis a history of bleeding
and tenesmus is common, and there is an
absence of a vascular pattern on sigmo
idoscopy. There is granularity of the mu
cosal line on x-ray, and here I may say that
we are strong advocates of the use of dou
ble-contrast enemas which show the un
evenness of the mucosal surface. We find
in biopsies that there is diffuse inflammation
with depletion of mucus in epithelial cells
where the mucosa is inflamed. There are no
chronic anal lesions, and there are no granu
lomas in the biopsy specimen.
Crohn’s disease is, of course, much more
difficult to define because it is so hetero
geneous. I will conclude with the simple
idea that ulcerative colitis is a disease that
is relatively easy to define, while Crohn’s
disease may merely be a label encompassing
a number of related but not necessarily
identical diseases.

91 attributes on which we had complete
data. We asked the computer to find the
smallest number of attributes that would
divide these patients into the two groups
and found that this could be done using
quite a small number of attributes.
Supposing we try to put the various attri
butes into patterns. For example, you exam
ine the anal canal with your finger and you
say that, if it feels smooth, you will grade
it as “ 1” and if it feels nodular, you will
grade it as “2”. Of course, if the patient
has had a fistula or an abscess, and the
anus is scarred, it will be nodular. This
then gives a simple definition of a large
number of anal diseases. Next, you pass a
sigmoidoscope and you find that there is a
completely normal vascular pattern through
out the entire rectum; we classify that as
“ 1”. If, on the other hand, you see vascular
patterns only in part of the rectum and
inflammation in other parts we classify this
as “2”. If we pass our sigmoidoscope and
there is a diffuse inflammation involving the
whole rectum and no vascular pattern is
visible, we will call it “3”. Then we take
a single rectal mucosal biopsy and give it
to the pathologist. If he finds it completely
normal, we call it “ 1” . If he finds it dif
fusely abnormal, we call it “3”. If he finds
a patchy abnormality, we call it “2”. Fi
nally, if he finds granulomas, we call it “2” ;
if there are no granulomas in the specimen
we call it “ 1”. Table I shows that we have
now a series of grades which we can divide
into various patterns. Let us suppose that
we take the patients in whom we have diag
nosed ulcerative edits, and look over our
patterns. Table II shows that there were
61 patients with colitis, and 57 of them fell
into one pattern. They all had a smooth
TABLE II.— P attern A nalysis

of

61 P atients

N o . o f p a tie n ts

A n a l canal

V a s c u la r p a tte r n

1
I
1*
57
1

1
1
1
1
2

2
2
3
3
3

61
'Overlap with Crohn’s disease.

with

P roctocolitis

I n f la m m a tio n

2
3
2
3
3

G r a n u lo m a s

1
1
1
1
1
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CROHN’S DISEASE

INTRODUCTION

OIAGKOETIC

JU T T R IA ?

hUKuXUU. i W i m i i O . . /

ACTUARIAL ANALYSIS Of RfCCf SENCC RATE? :

Fig. L—Recurrent ileitis after ileostomy fot
Crohn’s disease of the colon.

I shall introduce our first topic by show
ing a few provocative statistics. Fig. 1 in
dicates the recurrence rate in various series
after proctocolectomy for Crohn’s disease of
the colon. You can see that it is not clear
whether proctocolectomy in these cases is
followed by a high or a low recurrence rate
in the small bowel. One of these reports
even goes so far as to suggest that involve
ment of the terminal ileum does not affect
the recurrence rate. In these studies,
actuarial analysis of the data was not always
done and indications for surgery were not
identical.
What were the criteria used to make a
diagnosis of Crohn’s disease? Between 1885
and 1930, many reports of abdominal tuber
culosis were not supported by the demons
tration of caseation and acid-fast bacilli.
Kennedy Dalziel, in 1913, reported eight
peculiar cases to the British Medical As
sociation. The patients had chronic inflam
mation of the small and large bowel, trans
mural in nature, with giant cells. Dalziel’s

merit was to recognize that this was not
tuberculosis. Nineteen more years passed
before Crohn, Ginzburg and Oppenheimer
called the condition terminal ileitis. Bargen,
commenting at the time on their paper, sug
gested changing the name to regional ileitis,
because the adjective “terminal” could
sound ominous to the patients. In 1952,
Wells, in Liverpool, recognized that there
was a colonic variant of the disease but it
took the New World 15 more years to ac
cept this fact.
It was not until the 1968 International
Congress of Gastroenterology, in Prague,
that the term Crohn’s disease of the colon
was universally adopted. The term Crohn’s
disease seems to be the best choice at this
time. The alternative term “regional en
teritis” could indicate a disease occuring
anywhere from the mouth to the anus but
could not be applied to skin lesions remote
from the gastrointestinal tract.
G. J. DEVROEDE
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ETIOLOGY AND EPIDEMIOLOGY OF CROHN’S DISEASE
JOHN E. LENNARD-JONES
D r . D evroede has already brought to our

attention the difficulty of defining Crohn’s
disease. It is because of the lack of a simple
clear-cut definition that we have so much
difficulty in studying its epidemiology. Hav
ing defined what we understand by this
condition, we need to know the population
from which our patients are drawn in regard
to its size, age and sex distribution. We also
need to know how the patients have been
discovered among this population. Lastly,
in any epidemiological study we must know
which patients have been excluded.
The last point is extremely important.
For example, Evans and Acheson published
an interesting study from Oxford, England,
in 1965 but many of the patients they ex
cluded from their series were described in
detail and now we would regard these same
patients as having Crohn’s disease. So it
is very important that the excluded patients
should be listed and fully described.
Let us now briefly consider the diagnostic
criteria of Crohn’s disease. Crohn’s disease
at present can be diagnosed only on ana
tomical grounds. I suggested in 1971 that
the diagnosis can be made on the basis of
the following characteristics. The disease,
as it was originally described by Crohn and
his colleagues, tends to have a predilection
for the distal ileum. It is characterized by a
peculiar type of anal lesion and the frequent
presence of fistulas between the bowel and
the skin, or between the bowel and another
viscus. The disease tends to be discontinu
ous along the length of the gut or around
its circumference and it can involve any

portion of the intestinal tract from the mouth
to the anus. Turning to histology, Crohn’s
disease involves all layers of the bowel wall,
often showing peculiar, rather characteristic
fissures. The epithelioid type of granuloma
is not always present but probably occurs
in between one-half and three-quarters of all
patients. There is lymphoid hyperplasia and
mucin tends to remain in the goblet cells of
the inflamed colonic mucosa.
As will be described later, not all these
features are found in every case. There
fore, if we are going to define Crohn’s dis
ease, we have to have some sort of a scoring
system (Table I). I have suggested, and this
has not been universally accepted, that per
haps we might define Crohn’s disease by the
presence of the typical epithelioid cell granu
loma with one of the other features, or by
the presence of three of the other features
without the granulomas. You will notice
that some of the features can be diagnosed
clinically and some radiologically but one
also needs a biopsy or an operative speci
men to find the histological changes.
What has made epidemiological studies
difficult is that this disease affects different
areas of the gut and many of the earlier
studies were confined to regional ileitis
only. In an interesting study done in Basle,
Switzerland, by Fahrlander and Baerlocher
in 1971, the anatomical distribution of the
disease was analyzed and it was found that
in 34% of the patients the disease was con
fined to the terminal ileum, in 37% it af
fected the terminal ileum and colon, in 28 %
it involved the colon only and in 5% the

TABLE I.—D iagnostic F eatures

Ileal involvement................................
Anal involvement................................
Fistula...................................................
Discontinuity.......................................
Fissure...................................................
Granuloma............................................
Lymphoid hyperplasia.......................
Retention of mucin in goblet cells . .
Transmural extension.........................
Crohn’s disease = + + + or +*.

of

C rohn’s D isease

C lin ic a l

X -ra y

B io p s y

+
+
+
+

+
+
+
+
+

+
+
*

+
+

O p e r a tiv e s p e c im e n

+
+
+
+
+
+
+
+
*
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anus and rectum. I wish to draw your at
tention to the fact that the colon and the
ileum are involved in approximately 70%
of the patients.
When we consider epidemiology, we must
think in terms of geography, age and sex
incidence, and change with time. There
have been a number of studies done around
the world (Kyle, 1972 and Evans, 1972)
and these show that the disease is most
common in northwest Europe and North
America. It is much less common in South
America, probably even less common in
Australia, almost absent in southeast Asia
and in Africa. Within the United States it
is more common among Jews than among
non-Jewish people and it is also more com
mon among Caucasians than among black
people. There is also a very interesting varia
tion with age in that there tends to be a
maximum incidence between the ages of
20 and 40 years, and there is also another
peak later in life. Sex incidence varies in
different series but it is approximately equal
for men and women. There have been only
three studies in which all the known factors
were carefully controlled. One was done in
Sweden, one in northeast Scotland and one
in Switzerland. The incidence of Crohn’s
disease in these studies, that is to say the
number of new cases per 100,000 populatoin per annum, has been approximately
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equal, that is 2.5 in Sweden, 2.2 in Scotland
and 1.6 in Switzerland. Because Crohn’s
disease is a chronic disease, the prevalence,
that is the number of patients with this dis
ease per 100,000 of population on any
particular day, is of course greater; in
Sweden it is 27 and in Scotland 32.5. In
every series, the incidence has approximately
doubled over the last few years. It could be
argued that the diagnosis is improving but
there are valid arguments that this can only
partially account for the observed increase
in incidence.
Fig. 1 represents the figures of Dr. Rit
chie at St. Mark’s Hospital in London,
showing the age of onset of Crohn’s disease
and its distribution in the gut. You will
notice, as Crohn and others found, that the
peak incidence of primary small intestinal
disease is early in life, in the 20s and 30s.
Interestingly enough for disease affecting
the distal colon and rectum there is a peak
incidence between the ages of 50 and 70.
Why there should be this peak in Crohn’s
disease of the distal colon in the older age
group is quite unknown but it probably ac
counts for the fact that in the overall age
incidence of Crohn’s disease there is a peak
between the ages of 20 and 30 and a rise
later in life.
We do not know the cause of Crohn’s
disease but information can be derived from
Small Intestine t colon (137coses)

Fig. 1.—Age distribution and sites of involvement of Crohn's disease: 350 cases.
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various sources. I have just reviewed the
epidemiology and there have been one or
two interesting features worth noting. First,
it is common in some parts of the world and
uncommon in others. This suggests that
perhaps there is an environmental factor
operating in these countries. There is also
a suggestion in these series that this disease
is increasing in incidence in the developed
countries, again perhaps indicating a mod
ern environmental factor. Its common oc
currence late in life and its location
distally in the colon must be useful clues
but as yet they are not understood. Second,
we have some genetic data. In a series of
patients with Crohn’s disease there is an
increased prevalence of the disease among
the relatives. In our own series it is 130
times the expected prevalence in the general
population. There is another interesting
genetic relationship in that Crohn’s disease
is related to ankylosing spondylitis and the
latter disease is associated with one parti
cular tissue antigen, namely HL-A27. It is
also possible that Crohn’s disease is related
genetically to ulcerative colitis.
Fig. 2 summarizes some of the gross and
MACROSCOPIC

MICROSCOPIC
LYMPHOID AGGREGATES
MUCIN
GRANULOMATA
TRANSMURAL
Fig. 2.—Anatomical features of Crohn’s colitis.
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microscopic anatomical features of Crohn’s
colitis. Perhaps the most interesting feature
of morbid anatomy is observed in the study
of the early lesion and this may well be
ulceration of a small lymphoid follicle in
the wall of the gut. We know from conven
tional histology that there are lymphoid ag
gregates in the wall of the gut, and McGov
ern, in Australia, suggested that ulceration
usually begins with the aggregation of lym
phocytes around the base of a gland.
If we turn to electron microscopy (Aluwihare, 1971) there are again some interest
ing features. First, the epithelial cells are
not damaged where the bowel is not ulcer
ated. Hence it does not appear to be an
epithelial cell disease. On the contrary, there
is an increase in the number of lymphocytes
and plasma cells in the lamina propria and
the former differ from the ordinary lym
phocytes in having a rather prominent nu
cleolus. This is a change often seen when
lymphocytes are undergoing blast trans
formation, that is when they are immunologically stimulated. The epithelioid cells,
which are so characteristic of Crohn’s dis
ease, appear under the electron microscope
like macrophages. They contain many
lysozymes and a lot of acid phosphatase,
but they do not appear to be acting as pha
gocytes. Also of interest is that in areas of
the bowel remote from the disease bacteria
are found in the lamina propria. They are
not found in the wall of the normal colon
and are not found in ulcerative colitis. All
these features suggest that there is an im
munological disorder affecting lymphocytes,
plasma cells and macrophages, and the
presence of the bacteria in the lamina pro
pria perhaps suggests that the defence
mechanisms of the colon are ineffective.
I will not review the great amount of
immunological data on Crohn’s disease be
cause it is so conflicting. There are a number
of reports suggesting that there is a depres
sion of cellular immunity in Crohn’s disease.
For example, a very interesting recent study
has shown that the lymphocytes in this con
dition do not undergo the normal blast
transformation when exposed to the lym
phocytes of a patient with different tissue
antigens (Richens et al, 1974).
Lastly, and this is perhaps one of the most
interesting areas of investigation, we come

an em erging problem.
“Bacteroides species are often over
looked as a cause of serious infec
tion both by clinicians and micro
biologists. They are most commonly
associated w ith intra-abdominal
and pelvic sepsis following gastro
intestinal surgery.”

“Our experience with this series of seriously
ill patients provides clinical confirmation to
complement recent in vitro evidence that M
clindamycin is the antibiotic of choice for
use in bacteroides infections. Not only was <
the response in 17 of the 18 patients favour- u
able, but in several it was dramatic.”

Tracy, 0 .,e t al. (29 Jan.’72),
Brit. med. J., p. 280.

Haldane, E. V. and van Rooyen, C.E. (1972).
C.M.A.J.,p. 1177.

ic Abscess - surgical removal and drainage
e illu stra tio n tfie su rg e on is preparing to remove a righ t
su b p h re n ic ab sce ss. T h e p atie nt is in the nephrectom y p o sitio n ,
and the surge0p»tp<e(?put to m ake the initial in cisio n . H e t r ill
m an u a tly ’e k p io re th e fig h t extra-peritoneat.spacW .'W he'rt th e > .
,
a b sc e ss i^\epcountered, the fin p e r w in be pushed firm ly th ro u g h <
th e ^ a ll and the pus evacu ated with a sucker. Before c lo s in g ,
I 1,
a.sj?8in is p la ce d and brou g ht o u t through a sep arate sta b w o u n d '
tow the m ain in cisio n .

bacteroides infection

• I.M. injection or I.V. infusion
achieves prompt and high peak
serum levels of active clindamycin
• well tolerated locally and sys"temically following I.M. injection
or I.V. infusion
Upjohn

Daladnc
nosmale
S.
S
.
a new solution

T H E U P J O H N C O M P A N Y O F C A N A D A / 865 Y O R K M I L L S R O A D / D O N

M ILL S , O N T A R IO

Dalacinc Phosphate S.S.
in anaerobic infections
Indications: Dalacin C Phosphate has been found ef
fective in the treatment of certain infections due to
anaerobic bacteria, including Bacteroides species,
Peptostreptococcus, anaerobic streptococci, Clostrid
ium species and microaerophilic streptococci. It is also
indicated in infections due to sensitive Gram-positive
organisms, particularly streptococci, pneumococci and
staphylococci. As with all antibiotics, in vitro suscep
tibility studies should be performed.
DOSAGE AND ADMINISTRATION
Adults:

Intramuscular — 600 to 2400 mg*/day in 2, 3, or 4
equal doses. Intramuscular injections of more than 600
mg in a single site are not recommended.
Intravenous — 900 to 4800 mg*/day by continuous
drip or in 3 or 4 equal doses, each infused over 20
minutes or longer. Administration of more than 1200
mg in a single one hour infusion not recommended.**
Children (over one month of age):
Intramuscular — 10 to 30 mg*/kg/day in 2, 3, or 4
equal doses.
Intravenous — 15 to 40 mg*/kg/day by continuous
drip or in 3 or 4 equal doses, each infused over 20
minutes or longer.**
*Depending on the severity of the infection.
**Dalacin C Phosphate Sterile Solution should not be
given undiluted intravenously; always administer in an
infusion. See product monograph supplied with each
package for complete dosage information and infu
sion rates.
Cautions: Generally well tolerated. Known and usual
antibiotic administration route side effects have been
reported. Pain at the injection site, induration and
sterile abscess have been reported following intramus
cular injection. Thrombophlebitis erythema, swelling
and pain at the infusion site have been observed fol
lowing intravenous infusion. Cases of severe and per
sistent diarrhoea have been reported and have at times
necessitated discontinuance of the drug. This diarrhoea
has been occasionally associated with blood and mucus
in the stools and has at times resulted in an acute
colitis.
Abnormalities in liver function tests have been re
ported occasionally. Usual antibiotic side effects—rash,
urticaria, pruritus, fever, leukocytosis, nausea, diar
rhoea, changes in blood pressure, shortness of breath
and bad or bitter taste in mouth have been reported.
Not indicated in patients who have demonstrated sen
sitivity to clindamycin or lincomycin. Safety in infants
below 30 days of age or in pregnant women not estab
lished. Use with caution in patients with a history of
asthma and other allergies. As with other antibiotics,
periodic liver function tests and blood counts should
be performed during prolonged therapy.
Detailed information available upon request.
Availability:
Dalacin C Phosphate Sterile Solution - Each ml con

tains clindamycin-2-phosphate equivalent to clinda
mycin base 150 mg, in 1 ml and 2 ml ampoules.
MEMBER
738

REGISTERED TRADEMARK! DALACIN

U pjohn

CE 6957.2

T H E U P JO H N C O M P A N Y O F C A N A D A
865 Y O R K M IL L S R O A D /D O N M IL L S , O N T A R I O

Vol. 17

to microbiology. Many people have looked
for viruses and other infective agents in
Crohn’s disease without discovering one.
Recently, by analogy with leprosy, tissue
from lesions of Crohn’s disease has been
injected into the footpad of the thymectomized, irradiated mouse. This is a mouse
whose immunological defences have been
almost completely destroyed. Lesions devel
op but they develop slowly. It has now
been found that this granulomatous lesion
will also develop in an ordinary mouse and
the reason that this has not been found
before is probably that people have not
waited long enough. Now we know that one
must wait for months before the sarcoid
lesion appears. This original work has now
been extended by injecting tissue from the
lesions of Crohn’s disease into the intestine
of rabbits (Cave et al, 1973). When this is
done, a lesion develops which, perhaps, has
some of the histological characteristics of
Crohn’s disease but not quite as we see it
in humans. A more interesting observation
is that the lesion spreads in the intestine
and it can be passaged from one rabbit to
another; it has now been passaged to the
third generation. Whatever it is that can be
transmitted will pass through a 0.2 p, filter
and therefore it is not a bacterium. It could
be a virus or it could be something like an
L form of a bacterium.
How can we summarize this information?
We have noted that there is probably an
environmental factor. There is also evidence
that there may be an infective factor.
Genetic and immunologic data suggest that
perhaps some patients are particularly liable
to develop this disease and that this in
creased risk may be immunologically me
diated. This is perhaps where our knowledge
of the etiology of Crohn’s disease rests for
the present.
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CLINICAL FEATURES AND PROGNOSIS OF CROHN’S DISEASE
J. P. McMANUS
C r o h n ’s disease presents an ever-increas
ing challenge to clinicians despite great ad
vances on many biological frontiers. Since
the inflammatory process respects no ana
tomical boundaries, retention of the eponym
ous term may be justified. The clinical
features and complications are determined
mainly by the histological nature and the
anatomical site of the lesion and the func
tion of the part of the gut affected (Tables
I and II).
Inflammation is accompanied by the non
specific features of fever, malaise and
anorexia which may dominate the clinical
picture. When inflammation is extensive,
there is accompanying disturbance of func
tion. Gastroduodenal lesions are commonly
associated with dyspepsia or symptoms of
delayed gastric emptying. Involvement of
the small intestine is accompanied by dis
TABLE I.—R elationship
(1)

of

turbances of transit or regional disturbances
of absorption producing a varying spectrum
of deficiency syndromes. When colonic
function is compromised there will be diar
rhea, and if the vital reservoir role of the
rectum is also impaired the patient will
suffer from urgency and even incontinence.
Associated with ulceration, there is a loss
of blood and protein which, if extensive,
results in anemia and severe hypoproteinemia. These in turn may have a deleterious
effect on the function of other organs. Fis
tulas are characterized by an inappropriate
flux from skin surfaces or organ orifices; a
short-circuit connection between small and
large bowel results in fecal contamination
with resultant diarrhea and steatorrhea.
Fibrosis, a very common histological find
ing in this disease, causes stasis and colic.
It is now recognized that what used to be

P athophysiology

to the

N ature

of the

G ut L esion

Inflammation: fever, malaise, anorexia
regional disturbance of function—gastroduodenum
small bowel
colon

(2) Ulceration:

loss of blood, protein

(3) Fistulas:

inappropriate flux
bacterial contamination—diarrhea
short circuit—steatorrhea

(4) Fibrosis:

stasis, colic

TABLE II. —R elationship

of P athophysiology to the E xtent and A natomical
and the F unction of the R egion Affected

(1) Gastroduodenum: transit—pyloroduodenal “hold-up”
digestion — “a typical dyspepsia”
(2) Small intestine:
transit—hurry
stasis
obstruction
absorption—-regional differences
(3) Colon and rectum: absorption—water
electrolyte exchange
transit—hurry
hold-up
reservoir—urgency
incontinence
Plus: (a) perianal disease—fistulas, abscess, fissures or tags;
(b) skin involvement—perineum, buttocks;
(c) fistulas—gut, skin, genital or urinary tract.
Plus: Systemic complications—uveitis, arthritis, ankylosing spondylitis,
liver dysfunction, severe oral aphthous ulceration, skin problems.

S ite

of the

L esion
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regarded as strictures in the colon are in
fact more often areas of local muscle spasm
and hypertrophy.
The complications of Crohn’s disease can
be conveniently classified as psychological,
visceral, extravisceral, metabolic and iatro
genic.
In considering psychological disturbances,
it must be remembered that the disease very
often affects the young, individuals in their
prime, whose social, intellectual and sexual
life, indeed whose whole future, may be
severely interrupted and is to be disrupted
repeatedly because of the incurable, chronic,
progressive nature of the condition. One
must realize the catastrophic effects the
condition may have on the patient’s morale.
Diarrhea, urgency and incontinence may
make the victim bad tempered and this re
flects not his basic personality but the effect
of the disease on his psyche. Then again,
the situation may be aggravated by disturb
ing side effects, e.g. hirsutism, acne, or
obesity in patients receiving large doses of
corticosteroids for prolonged periods of
time.
Of the visceral complications, the perianal
fistulas, fissures, abscesses and redundant
edematous skin tags are the most readily
recognized. The visceral manifestations, fis
tulas and strictures have already been men
tioned. In my own experience severe colonic
bleeding is more a feature, albeit very rare,
of granulomatous colitis than of ulcerative
colitis. Toxic dilatation reflecting severe
disease advancing on a broad front is a less
demanding but a rare manifestation of
colonic involvement. Perforation is also a
much less common sequel than in ulcerative
colitis.
Five or six years ago it would have been
agreed that there was no increased risk of
malignant disease associated with Crohn’s
disease. Then, in the beginning of 1973, a
report from London and later in the same
year a study from the Mayo Clinic leave
no doubt that there is an increased incidence
of malignant disease of the large bowel, of
the order of 20- to 30-fold, and a strong
suggestion of an increased incidence of
carcinoma of the small intestine associated
with chronic Crohn’s disease. What, then,
are the implications for the patients and
clinicians? Should we be screening these pa
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tients for carcinoma antigens? Should we
use colonoscopy and, when the instruments
become available, should we be passing en
teroscopes routinely? Should a constant
watch for pre-malignant changes in rectal
biopsies be maintained? Personal experience
suggests these changes are not necessarily
always present in patients who develop car
cinoma of the colon complicating ulcerative
colitis.
It is evident that the same spectrum of
extravisceral manifestations may occur with
Crohn’s disease as with ulcerative colitis,
although in general less frequently than in
the latter condition. Oral aphthous ulcera
tion can be a severe problem and on occa
sion has tilted the balance in favour of
surgery in patients with chronic intractable
disease. The skin manifestations may not
always correlate well with the state of activ
ity of the disease. As regards the hepatic
lesions, fatty infiltration, pericholangitis,
chronic active hepatitis, cirrhosis, granulomata, amyloid deposits and hepatic abscesses
have all been described. Only cholangitic
carcinoma, which rarely occurs as a com
plication of ulcerative colitis, has not yet
been documented in patients with Crohn’s
disease.
In all fairness it must be kept in mind
that the incidence of these extravisceral
manifestations in Crohn’s disease as well
as in ulcerative colitis, reflects the skill and
the enthusiasm of the centre reporting. Thus
an ophthalmic group and a rheumatology
unit will report a high incidence of eye com
plications and of arthropathy respectively
compared with other series. There is an
association of ankylosing spondylitis with
Crohn’s disease and an increased family in
cidence of both of these conditions with
ulcerative colitis. McConnell has suggested
that this is the result of overlapping geno
types. Time does not permit discussion of
the renal manifestations such as fistula
giving rise to infection, hydroureter, the
increased incidence of renal calculi and the
possibility of amyloidosis.
The nutritional and metabolic complica
tions are common, but happily they respond
quite rapidly to successful treatment of the
underlying disease. They are of considerable
practical interest and often may be im
portant manifestations of the disease. The
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mechanisms involved are often multiple.
There may be malnutrition because the pa
tient does not want to eat against a back
ground of a catabolic process, the result of
the inflammatory disease. The situation may
be aggravated by a degree of malabsorption
caused in turn by various factors, com
pounded by increased loss from the bowel.
There may be a subocclusion producing
bacterial proliferation with its accompanying
disturbances of absorption or, paradoxically,
there may be an increased rate of transit
interfering with proper digestion and absorp
tion of nutrients. Often there is anemia,
again multifactorial, caused by nutritional
factors, increased loss of blood, malabsorp
tion and marrow depression, now recognized
as the so-called anemia of chronic disease.
The whole situation can be aggravated by
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hemolysis or, more rarely, marrow depres
sion related to Salazopyrin therapy. Azathioprine can now also be added to the list
of potentially toxic drugs used in the treat
ment of this disease. The hypoalbuminemia
may be a reflection of the diminished in
take, increased loss, increased catabolism
and, perhaps, impairment of liver function.
Iatrogenic complications must always be
considered in view of the barrage of non
specific therapy that may be administered
over a long period of time. The three main
lines of therapy, namely corticosteroids,
Salazopyrin and azathioprine, all have wellrecognized side effects. An increased un
derstanding of the metabolism of these drugs
can markedly diminish the incidence of side
effects and increase the therapeutic benefits.
Complications of surgical techniques have
become less frequent through the abandon
ment of side-to-side intestinal anastomosis,
increased understanding of the metabolic
sequelae and implications of intestinal re
section, and the avoidance of ileostomy
in patients who have Crohn’s disease of the
small bowel.
Finally, in regard to the difficult, frustrat
ing area of prognosis, the recent study at
the Mayo Clinic confirms the reduced surv
ival in patients with Crohn’s disease (Fig. 1).
It is perhaps noteworthy that the survival
has improved since 1953, i.e. about the
time that corticosteroids became available.
The
value of surgery and its role in de
Fig. 1.—Results of a Mayo Clinic study show
ing survival rates of 449 patients with Crohn’s termining the long-term prognosis will be
discussed by other contributors.
disease.
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ENDOSCOPY IN CROHN’S DISEASE
G. J. DEVROEDE
T h e presence of extensive indolent anal and
perineal ulcerations, with numerous deep
fistulas, is a classical feature of Crohn’s
disease. The miliary tubercles that sur
round the ulcerations contain granulomas
(Fig. 1; other lesions are seen in Fig. 2).
The fistulous abscesses are not always as
extensive. One can see (a) the opening of a
fistula in the anterior midline of the anal
canal just at the level of the dentate line.
This patient had an ischiorectal abscess with
characteristic histological lesions of Crohn’s
disease and no lesions anywhere else in
the gastrointestinal tract. This is a case of
Crohn’s disease of the anus. Occasionally
patients with Crohn’s disease elsewhere in
the gastrointestinal tract have anal fissures
(b) such as these which do not have particu-

Fig. 1.—Anal and perineal ulceration in Crohn’s
disease.

Fig. 2.—(a) Crohn’s disease of the anus. A fis tula opens in the anterior midline of the anal canal
at the level of the dentate line, (b) Anal fissures, (c) A granuloma was found under the reddish spot
in the centre of this picture. The mucosa was intact. This represents one of the earliest visible lesions
of Crohn’s disease in the colon, (d) Punched-out ulcerations, (e) Linear ulceration, (f) Scar of a
previous granuloma representing resolution of a lesion. (Published by courtesy of the Olympus Cor
poration of Canada, G. D. Searle & Co. of Canada Ltd. and the ACMI Company.)
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lar characteristics and are not indolent but
are painful. Present and Janowitz found
epithelioid granulomas in 8% of the pa
tients who had Crohn’s disease and a nor
mal sigmoidoscopic appearance with a pin
kish mucosa and a normal vascular pattern.
The use of commercial hypertonic enemas
such as Fleet or Travad may be responsible
for minor changes observed at endoscopy.
One can still recognize the vascular pattern
but there is a reddish appearance of the
mucosa which might be mistaken for an in
flammatory reaction. Petechiae may appear.
The earliest lesion of Crohn’s disease that
can be recognized at endoscopy is very simi
lar in appearance. The reddish spot in the
middle of the photograph (c) was biopsied
and a classical granuloma was found. This
picture illustrates the difficulty in recogniz
ing early lesions at proctoscopy. With more
extensive disease (d) punched-out ulcera
tions may be found. In our experience
Crohn’s disease of the colon is the most
common cause of localized ulcerations in
the rectum and sigmoid. The mucosa be
tween the ulcers may be completely normal,
or in acute bouts of the disease it may be
edematous and inflamed. Figure (e) shows
one of the most characteristic lesions of
Crohn’s disease. The linear, longitudinal
ulceration was biopsied and granulomas
were found underneath. This should not be
confused with that caused by a proctoscope
which has a slightly curvilinear appearance.
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Another type of trauma can result from the
too forcible introduction of an enema can
nula by a nurse. It may also be seen after
insertion of a proctoscope or a thermometer.
Classically this traumatic ulcer is found at
the anorectal angle.
In some cases fistulas occur and may be
seen. Finally, lesions of Crohn’s disease may
disappear. At (f) the whitish area in the cen
tre is the scar of a previous granuloma. The
patient had a stenosing lesion in the small
bowel. In the rectum there was a tuft of
granulation tissue containing giant cells and
typical granulomas. The small bowel was
resected because of obstruction and the pa
tient was subsequently treated with Salazopyrin. Three years after surgery she is com
pletely asymptomatic and has no evidence of
recurrent disease. At proctoscopy the area
where giant cells and granulomas had been
found is completely epithelialized and only
this scar is to be seen.
In summary, the main feature of Crohn’s
disease of the rectum is the localized rather
than diffuse pattern of the lesions. As a con
sequence the vascular pattern can be fre
quently identified. Characteristic lesions
may be small erythematous areas, linear
ulcerations or more extensive undermining
ulcers. Crohn’s disease, in contrast to ulcer
ative colitis, may spare the distal part of the
bowel. Follow-up of patients with colitis
without rectal involvement demonstrates
that they usually have Crohn’s disease.

HISTOPATHOLOGY OF CROHN’S DISEASE
M. LERICHE

T he pathological diagnosis of Crohn’s dis
ease is based on the detection, after a
careful search, of a pattern, rather than of
isolated diagnostic features. The histological
signs of this disease are numerous and,
when grouped together, form a character
istic pattern. Taken individually, none of
the signs are specific and they can be found
in widely varying afflictions of the gastro
intestinal tract such as tuberculosis and
ulcerative colitis.

The sarcoid reaction, when present, is a
most helpful histological sign. As shown in
Fig. 1, the typical lesion is composed of a
few giant cells of the Langhans type sur
rounded by some epithelioid cells and a thin
rim of lymphocytes. There is also a sur
rounding inflammatory sclerosis. Caseation
and Koch’s bacilli are absent from the
granuloma but there may be a patch of
fibrinoid necrosis in its centre, making the
interpretation of the lesion difficult. More
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often than not the pathologist is confronted
with a more rudimentary form of the
sarcoid reaction, a lesion without giant cells
and consisting mainly of a few reticular
cells surrounded by lymphocytes. The sar
coid lesion is seldom abundant and, accord
ing to Lockhart-Mummery and Morson, it
is completely absent in about 40% of the
patients with Crohn’s disease. When present
it can be seen in any portion of the in
testinal tract and in all layers of the bowel
wall. It is most common in the submucosa
and the serosa. When it is confined to the
serosa only, a foreign-body granuloma must
be excluded. Besides the bowel wall, lymph
nodes, the liver and the skin may also con
tain granulomas.
The absence of sarcoid lesion, while not
excluding the diagnosis of Crohn’s disease,
demands a search for fissures which form
the next important histological feature of
this disease. These fissures, as shown in Fig.
2, start from the mucosal surface and run
deeply into the bowel wall forming vertical
clefts with both sides lined with poly
morphonuclear cells enmeshed in a fibrin
net. This feature distinguishes a true fissure
from an artefact. Like sarcoid lesions, fis
sures are also relatively rare and careful
scrutiny of many sections is required to

Fig. 1.—Sarcoid reaction in Crohn’s disease. A
typical lesion showing giant cells surrounded by
epithelioid cells and a rim of lymphocytes. There
is no caseation.

Vol. 17

discover them. Again, fissures are not
specific for Crohn’s disease and may be
seen in lymphomas and ulcerative colitis.
The fissures found in ulcerative colitis do
have some distinguishing features, however.
They are usually horizontal, symmetrical
and have a hook-like appearance. The fis
sures are usually regarded as the earliest
form of intramural abscesses and fistulas.
More often than not, the mucosa is
healthy except in the small areas where ulcers
and fissures are present. The glands of the
mucosa are normal but there may be areas
of Brunnerian metaplasia or atrophy. Crypt
abscesses may be present in the mucosa and
these must not be regarded at pathogno
monic of ulcerative colitis. The tunica
muscularis mucosae is normal except when
it is involved by the ulcers.
The submucosa is always noticeably
thickened and abnormal. In the early stage
there is edema; in the more advanced cases
a chronic fibrous inflammatory process con
sisting of two major components is present.
The first of these is the granulomatous reac
tion already described. The second compo
nent, always present, is an inflammatory
reaction showing lymphocytes and plasma
cells. Frequently there are lymph follicles,
somes showing germinal centres and dilated
lymphatic channels. In this layer, parti
cularly, endarteritis and thrombosis can be

Fig. 2.—A fissure forming a vertical cleft with
its origin at the mucosal surface.
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found. The myenteric nerve plexus is often
prominent, probably owing to edema of the
bowel wall rather than to any intrinsic
changes in the plexus.
The submucosa is widened and altered by
inflammatory sclerosis. At times it con
tains lymph follicles attached to the my
enteric layer. In the mesenteric lymph nodes
we have observed lymphatic stasis with
widened sinusoids and the occasional
sarcoid reaction. To sum up the foregoing
description, one can say that the only mi
croscopic feature present in all patients is a
thickened bowel wall with transmural in
flammation.
Crohn’s disease may affect every portion
of the gastrointestinal tract and the various
topographic forms may have certain peculiar
histological features of their own. In the
colon the mucosal ulcers are larger than
those found in the small bowel. The in
flammatory polyps classically described in
ulcerative colitis may also be present in
Crohn’s disease of the colon. Sometimes
these inflammatory polyps form peculiar
bridges. I wish to emphasize that the mu
cosal bridges of ulcerative colitis are very
different from the ones observed in Crohn’s
disease. In the former there are true bridges
of mucosa creeping over polished mucosa
giving the appearance of oilcloth. In
Crohn’s disease the bridges are irregular
channels through a sclerotic wall, forming a
lace pattern (Fig. 3). Crypt abscesses are
not uncommon in Crohn’s disease, as are
metaplasic cells of the Paneth’s cell type.
Granulomas are more frequent in the colon
than when the disease is seen in the small

Fig. 3.—Probes demonstrate the presence of
mucosal bridges in Crohn’s disease.
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bowel. In the colonic form the nodular
aspect of the inflammatory reaction is often
absent, the bowel wall showing a rather uni
form diffuse infiltration by inflammatory
cells. Diverticular disease of the colon is not
uncommonly associated with Crohn’s dis
ease and an erroneous clinical and patho
logical diagnosis may lead to incomplete
resection of the diseased bowel with an in
creased likelihood of postoperative compli
cations. In the anorectal form the histo
logical signs are the same as those already
described. In this form, however, the lesions
are readily accessible to direct examination
and biopsy. When taking multiple biopsies,
one should remember that normal looking
mucosa may already show characteristic mi
croscopic changes. With regard to the pro
gression of the disease, two points deserve
particular emphasis. In the early phase the
pathologist is almost never consulted be
cause the patient receives medical therapy
or, if he is operated upon, a biopsy of the
involved area is not taken. However, in a
few specimens of the early lesion, marked
edema of the bowel wall, hyperplasia of the
lymph follicles in the subcucosa and, at
times, minimal ulceration on the superficial
aspect of the lymph-node follicle have been
observed. The second point worth em
phasizing is that in a phase of remission,
mucosal ulcers may become scarred and
covered over by regenerative type of mu
cosa with rudimentary glands and some
Paneth’s cells. The tunica muscularis mu
cosa never regenerates completely and the
new mucosa usually lies drectly against the
submucosa.
In summary, the most important histo
logical signs leading to the diagnosis of
Crohn’s disease are broad submucosal in
volvement, vertical fissures, sarcoid reac
tion either in the intestinal wall, the lymph
nodes or the anal lesion, small ulcers of the
mucosa, healthy mucosa between ulcers,
transmural inflammation with lymphoid
follicles, sclerosis of the wall, and changes
in the arteries and nerves. Individually,
none of these features are pathognonomic
and the diagnosis of Crohn’s disease conti
nues to pose problems for the histopathologist. Perhaps the discovery of an etiologi
cal agent will put the diagnosis on a firmer
basis.
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RADIOLOGICAL FEATURES OF CROHN’S DISEASE
B. G. STROM

C ha ra cteristic changes of granulomatous
disease of the bowel, also known as Crohn’s
disease, include mucosal changes, ulcers,
fistulas and abscesses and thickening of the
whole bowel wall. All these changes are re
flected in the various signs seen at the radio
logical examination. A complete description
of the radiological features of this disease is
not the object of this presentation and,
therefore, only a few typical examples of ra
diological signs will be presented with com
ments on the differential diagnosis. The
discussion will be limited to bowel disease,
leaving urological complications, bone in
volvement and other complications aside.
Granulomatous disease of the gastro
intestinal tract has been described from the
mouth to the anus but the typical and dia
gnostic changes are best seen in the small
and large bowel. The mucosal changes give
a typical granulomatous appearance to the
intestinal mucosa, completely different from
the normal, delicate pattern (Fig. 1).
Ulcers show as barium-filled clefts or
crypts outside the lumen (Fig. 2) and
fistulas may be outlined by the contrast
material. Sometimes a fistula is shown
as a short circuit to other bowel loops,
often between the terminal ileum and the
sigmoid (Fig. 3). An abscess most often
is seen as a space-occupying lesion, often
with compression of adjacent bowel loops,
sometimes
simulating
an
appendiceal
abscess (Fig. 4). Most of the enterocutaneous fistulas appear in the postoperative
period and sometimes fistulography is
necessary to identify the whole tract. Thick
ening of the bowel wall and mesentery is
seen as a separation of bowel loops. Also,
the presence of non-flexible loops of bowel
with long curves contrasts with the grace
ful pliability of normal small bowel (Fig. 5).
Stenotic lesions cause a pre-stenotic dilata
tion, often the site of food retention. Forma
tion of enteroliths has also been reported.
In the usual case the diagnosis is not dif
ficult, particularly with the help of clinical
information but sometimes, especially with
ileocecal involvement, intestinal tuberculosis

has to be considered in the differential
diagnosis. A useful sign of Crohn’s disease
is the so-called string sign which does not
occur in tuberculosis.
Attempts have been made to assess the
diagnostic value of various radiological
signs. Apparently contraction, stenosis and
rigidity are the most conclusive signs, fol
lowed by mucosal irregularities and ulcers
and clefts. The interpretation of skip lesions,
fistulas and mucosal-fold thickness is more
difficult and subjective.
In the large bowel interpretation is more
difficult because fewer typical changes are
seen. Mucosal changes, ulcers and fissures,
skip lesions and, in long-standing cases,
shortening and stenosis can be demon
strated, but thickening and rigidity of the
wall and edema of the mesentery are not
clearly shown (Fig. 6). Tuberculosis may
mimic Crohn’s disease but the main dif-

Fig. 1.—Granulomatous changes in the terminal
ileum and cecum.
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Fig. 3.—Fistula between the terminal ileum and sigmoid.
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Fig. 4.—Abscess from Crohn’s disease present
ing as space-occupying lesion.

Fig. 6.—Granulomatous colitis.
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Fig. 5.—Rigid ileal loops in Crohn’s disease.

Fig. 7.—Skip lesions in the hepatic flexure with
rectal sparing in granulomatous colitis.
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ficulty is in differentiating ulcerative from
granulomatous colitis. The location of the
disease may give a clue. Ulcerative colitis
is generally seen in the rectum, with ex
ceptions varying from series to series. In
the large series from St. Erik’s Hospital in
Stockholm, of 490 patients with ulcerative
colitis only 2% did not show changes in
the rectum. On the other hand, in the same
institution in 149 cases of Crohn’s disease
there was rectal involvement of moderate
degree in 39% while 91% showed in
volvement of the terminal ileum. In
ulcerative colitis a change called “back
wash ileitis” may be seen in the terminal
ileum but its radiological appearance is
quite different from that of granulomatous
ileitis, showing a wider, smoother, hypo
tonic terminal segment. Other criteria in
clude the type of ulcer encountered. In ul
cerative colitis these are mostly of uniform
size and shape, whereas in granulomatous
colitis many different forms and sizes
coexist. A retrospective British study
reports that the following features are com-

Fig. 8.—Marked thumbprinting in a case of
ischemic colitis.
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mon to both diseases: thumbprinting, coarse
serration and shallow ulcers, swollen mu
cosal folds and decreased length and calibre
of the bowel. Signs which are fairly sug
gestive of ulcerative colitis include total
large bowel involvement, rectal involve
ment, fine serration and absence of
haustration. Even more significant are a
smooth contour of the wall, the presence of
pseudopolyps and hazy longitudinal folds.
On the other hand the signs that favour the
diagnosis of granulomatous colitis are rectal
sparing, proximal colitis, terminal ileitis, skip
lesions (Fig. 7), abnormal haustrations, asym
metry of the lumen, deep ulcers, nodularity
or cobble-stone appearance of the mucosa
and fistulas and abscesses.
The absence of some of the signs may be
more helpful than the presence of others.
For instance, the absence of involvement of
the rectum or of the terminal ileum is in
itself strongly suggestive of the diagnosis.
The evolution of some cases has to be fol
lowed before a definitive radiological dia
gnosis can be made. In the distal colon the
most prominent feature may be thumb
printing and ischemic bowel disease must be
considered in the differential diagnosis
(Fig. 8). In such cases angiography is most
helpful.
Finally, the necessity of performing
barium studies in all suspected cases must
be emphasized, especially in patients pre
senting signs of partial obstruction with
spontaneous and rapid recovery. Dilated
pre-stenotic small bowel loops may simulate
colon on the plain films, or may be com
pletely filled with fluid and thus not be
visible. A complete radiological work-up,
with small bowel series and barium enema,
is necessary to detect these cases before fibrotic stenosis makes a resection or a by
pass the only therapeutic choice. The pre
sence of enteroliths on the plain films should
make the radiologist suspicious.
Patients with fever of unknown origin
should undergo extensive gastrointestinal in
vestigation, even in the absence of suggestive
symptoms.
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MEDICAL TREATMENT OF CROHN’S DISEASE
JOHN E. LENNARD-JONES
A t present there is no medical cure for
Crohn’s disease, but I do think that medical
treatment has some contributions to make,
in three ways. One tries to reduce the in
flammation in the gut, to correct nutritional
disturbances which, as Dr. McManus has
shown, are rather common and, when we
cannot do anything else, to relieve the pa
tient’s symptoms.
Let us first of all try to reduce inflamma
tion. We have various drugs available for
this purpose. There are antibacterial agents,
by which I mean sulfonamides other than
salicylazosulfapyridine and, of course, anti
biotics. These do not have, as far as I know,
any specific role but they are sometimes
useful. I suspect that they exert their bene
ficial effect by decreasing secondary infec
tion. A drug that I have found useful but
for which there has been no controlled trial
as yet is ampicillin. I use it under particular
circumstances and I certainly do not use it
on every patient. More interest focuses on
the drug that we in the United Kingdom
call sulphasalazine, which is marketed in
Europe as Salazopyrin and in the United
States as Azulfidine. This is a compound
of sulfapyridine and 5-amino-salicylic acid.
There has been as yet no controlled clinical
trial of this drug in Crohn’s disease. There
are, however, trials in progress in Scan
dinavia and we are conducting a controlled
trial in Britain. The results are not yet avail
able. I cannot tell you, on the basis of these
trials, whether this drug is useful in Crohn’s
disease, nor can I tell you how it works. All
I can say is that in some patients with
Crohn’s disease it does appear to have some
beneficial effects and often it is worth try

ing in a given patient. More than this we
cannot say at the moment.
We come, then, to the corticosteroids and
Dr. McManus has shown us that the mor
tality from Crohn’s disease changed after
1953. Whether this was due to corticosteroids
or not is still an open question because
there has been a greatly different attitude in
the treatment of Crohn’s disease in recent
years. Corticosteroids are very widely used.
Extraordinary as it may seem, there has
been no direct controlled trial of these
drugs in Crohn’s disease. The difficulties of
conducting controlled trials in this disease
are extreme. Our attempts to undertake such
trials have usually failed. This is explained
by the diversity of the disease in regard to
its anatomical distribution, its acuteness or
chronicity, as well as other differences, all
making it extremely difficult to obtain
matched groups. Most data on cortico
steroids, therefore, are retrospective, but
there is some indirect evidence from con
trolled trials— particularly of azathioprine—
that corticosteroids do play a part in man
agement.
Table I presents the data of Drs. Cooke
and Fielding from Birmingham, England.
They analyzed the effects of corticosteroids
in their patients using a number of different
parameters, clinical, hematological and bio
chemical. They found that, of the 89 pa
tients in their series, 14 had an apparently
good response, 54 had a fair response and
21 had no response. An interesting point
is the number of months that elapsed be
tween the diagnosis and the treatment of
this disease. For those who had a good
response, the mean number of months from

TABLE I —C linical R esponse to T reatment R elated to the I nterval B etween D iagnosis
C rohn’s D isease and the Start of T reatment*
Good response
No. of patients......................................
Months from diagnosis (mean). . . .
Significance of difference. . . . . . .

..........
..........
..........

14
19.14
P < 0.01

of

Fair response

Poor response

54
56.17
P < 0.01

21
91.33

♦Reproduced by permission from C ooke WT, F ielding JF : Corticosteroid or corticotrophin therapy in
Crohn s disease (regional ileitis). Gut 11:921,1970.
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diagnosis was 19; for those who had a fair
response, it was 56 months; and those who
had no response, 91 months. These differ
ences are statistically significant. We may
judge from this that steroids perhaps have
their greatest role in the patients with the
shortest history. This, of course, is not sur
prising. My impression is that these drugs
have two main uses. First of all, in a pa
tient with a short history and acute symp
toms, they may induce clinical remission,
and in these circumstances they may be
given for a short period of time. There are
other groups of patients, particularly those
with very extensive disease of the small in
testine, where surgical treatment is not ap
plicable, or those who have had multiple
resections of small intestinal lesions, in
whom the long-term use of corticosteroids is
permissible and useful. I do not believe
that corticosteroids remove the underlying
disease process, they merely suppress it;
in such patients suppression is worth while
and the risks of corticosteroid therapy are
justifiable.
In another series of patients it has been
shown that those on long-term cortico
steroids have a higher mortality than pa
tients not so treated (Prior et al, 1970). The
difficulty with such an analysis is that usual
ly it is the most severely affected patients
who tend to be treated with corticosteroids.
The other problem with this particular
series is that the causes of death in the
steroid-treated group of patients are uncom
mon. In my own experience and that of
others the complications reported have not

Fig. 1.—Progression of mean disease activity
score in patients receiving prednisolone with or
without azathioprine for Crohn’s disease. (Repro
duced from W illoughby JM, K umar PJ, B eck 
e t t J, et al: Controlled trial of azathioprine in
Crohn’s disease. Lancet 2: 944, 1971.)

403

been met. So while I do not doubt the data
the authors record, I am not sure that it is
generally applicable.
We must now consider immunosuppres
sive drugs, and in particular, azathioprine,
the one most commonly used. At present
the situation is rather confused. Azathio
prine was introduced some years ago by
Brooke and his colleagues with some en
thusiasm. Since the initial optimistic reports,
some controlled trials have proved possible.
I know of five such trials, through publica
tions and personal communications. Fig. 1
presents the data from a controlled trial by
Willoughby and his colleagues (1971) at
St. Bartholomew’s Hospital in London. They
scored the activity of the disease according
to a point system using symptoms, hema
tologic and biochemical findings, and vari
ous clinical manifestations of the disease. In
Group I the patients had acute symptoms,
and in Group II the disease was in remis
sion at the start of the trial. The patients
with acute symptoms were treated with cor
ticosteroids with or without azathioprine. As
shown in the figure, the symptoms scores
decreased and the patients improved. At
this point the steroids were withdrawn. In
those receiving the placebo the symptoms
became worse again, but those treated with
azathioprine tended to remain well. In
Group II the patients in remission started
out with a low activity score. The steroids
were then withdrawn. In those given a place
bo the symptoms became worse, but in
those taking azathioprine tablets, while the
symptoms became a little worse they were
not as severe as in the controls.
While this is the most convincing trial to
date suggesting that azathioprine may have
a place in the treatment of Crohn’s disease,
one other published trial showed no bene
ficial effects from the use of azathioprine.
This was conducted by Rhodes and his col
leagues (1971) from Cardiff, Wales, whose
patients had very chronic Crohn’s disease.
The patients received azathioprine or a con
trol tablet for two months according to a
cross-over scheme, and no benefit from the
azathioprine was demonstrable. I do not find
this very surprising because of the type of
patient treated. Two other trials have been
reported to me in which no benefit from
azathioprine was evident.
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The conclusion from all this is that azathioprine is not a wonder drug, nevertheless
I think it has a role in the treatment of
some patients with Crohn’s disease. My
practice is to use it when there is a real
therapeutic problem, and it has been my
impression that sometimes it is useful but
not always. We use it in a dose of 2 mg/kg
body weight/day, and with this dose hema
tological complications are almost unknown.
I am not going to dwell on the subject
of nutrition because it is so familiar to you.
The greatest nutritional defect is of calo
ries. The patient is thin and the weight loss
is often the result of an inadequate intake
of calories, combined with loss of protein.
We all know that resection of the terminal
ileum can lead to vitamin Bn deficiency and
such patients need replacement of the vi
tamin indefinitely if there has been a large
or total ileal resection. Dr. McManus has
mentioned the apparent iron deficiency
which may be due to marrow depression. I
would urge you to measure not only the
serum iron but also the total iron-binding
capacity because, if both parameters are low,
you can give the patient as much iron as
you like but it will not raise his hemoglobin.
Lastly, a few words about symptomatic
treatment. When there are strictures in the
intestine and surgical treatment is not ad
visable for some reason, a low-residue diet
may help. I am not a great believer in lowresidue diet, but this is a positive indication.
Treatment of diarrhea due to passage of bile
acids into the colon is important, but I do
not have the time to discuss it further. The
physician may have a role in the manage
ment of some of the anorectal complications
with the topical application of corticosteroids,
but more often their treatment is surgical.
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SURGICAL TREATMENT OF CROHN’S DISEASE
FRANK L. WEAKLEY
W e , as surgeons, must always remember
that we are dealing with a disease where
the results of surgical treatment are most
unsatisfactory in many cases. Therefore, we
must think of Crohn’s disease as primarily a
medical disease where surgical management
enters only when there are complications.
Also, we must not think that the neces
sity for an operation is caused by the failure
of medical management but, rather, that the
surgeon and internist are working together
to treat the various manifestations and com
plications of a disease for which we do not
have a specific cure.
When to operate is of course the first
question to answer. And, generally speaking,
an operation should be considered at the
time when all parties concerned— intern
ist, surgeon and patient— feel that the pa
tient’s future is threatened, or his perform
ance falls short of his desires or inherent
capabilities. Of course, when unrelenting
toxicity is present in spite of all non-operatiye management, or when there is obstruc
tion which may be the predecessor of a
massive nutritional deficit, or when a per
foration with abscess formation or other
septic complications exists, then there is an
absolute or near-absolute indication for
surgical treatment. Now, having placed sur
gery in its proper perspective with regard
to the treatment of the patient with Crohn’s
disease, perhaps it would be appropriate for
us to discuss management in terms of
specific do’s and don’t’s for the surgeon.
There are, definitely, some surgical problems
that can be avoided and there are certain
things the surgeon can do to assist the pa
tient’s recovery.
The first thing for the surgeon to remem
ber is not to disturb the diseased bowel
unless he intends to resect it. Do not divide
adhesions and do not mobilize bowel "just
to be able to examine it better. The reason
for this is that many of the adhesions have
a lumen and we have encountered adhesions
that, when divided, showed fistulization visi
ble to the naked eye. Now this is not limited
to massive adhesions, for often the “banjo

string” type adhesions when divided, al
though they do not show gross fistulization
at the time of laparotomy, will prove to have
at least potential openings present on micro
scopic examination. The fissures so well
shown in an earlier presentation, are an ex
cellent example of this because microscopi
cally there is total destruction of the normal
bowel architecture with a severe inflamma
tory reaction in the surrounding area. Divi
sion of these adhesions allows the inflam
matory mass to find a way to drain, resulting
in fistulous tracts and abscesses.
Sometimes Crohn’s disease is severely
interfering with the patient’s well-being and
health and yet it is all anterior; by that I
mean it is confined to the bowel and its
mesentery and therefore removal of the in
volved portion of the bowel with reanasto
mosis removes the disease. The difficult
decision for the surgeon is, of course, where
to transect the bowel. Sometimes it is very
difficult to find the correct site but there
are signs— often very subtle— which can
be helpful in selecting the proper place of
resection. For example, the obliteration of
the mesentery-bowel angle is an indication
of the presence of the disease. Also, the
serosal changes which are often quite subtle
will mark the abnormal bowel, even though
obstruction is present and the non-involved
portion of the small bowel is dilated and
hypertrophied. Because these signs may be
quite subtle, the presence of lymphadenopathy adjacent to the bowel— not in the
central nodes but in the small nodes along
side the straight vessels that run to the bowel
from the vascular arcades— is a more
helpful indication of the presence of dis
ease. When lymphadenopathy in this area
diminishes, the place for resection is more
readily demarcated. It has already been
alluded to, and most of us are aware, that
one of the sources of many iatrogenic com
plications in the past has been the indis
criminate use of a bypass type of operation,
rather than an exclusion, in the surgical
treatment of Crohn’s disease. Of course this
does not do anything to cure the disease,
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for the intestinal contents still have a choice
of two ways to go and they tend to follow
the normal route and the disease is allowed
to smoulder and progress. So this is the
wrong type of definitive operation when there
is active disease and the only time when it
would be of help is in the very few cases
where the disease activity has ceased but
residual bowel obstruction is present. Of
course we all know the world-famous case
of President Eisenhower; his disease was
not active and this fact was recognized by
the surgeon at the operating table and the
bypass type of operation was done, because
his problem was not toxicity but mechanical
obstruction.
Exclusion of the disease, if it is truly a
complete exclusion, will render the patient
temporarily well, but one should always plan
a resection of the diseased segment later.
And so, in the case of the disease that is
non-obstructive, the surgical closure of the
more normal adjacent bowel, with an ex
cluding type of anastomosis, will allow the
patient to return to better nutritional health
at which time the disease can be more safely
removed. One must remember, however,
that the disease may flare up in the excluded
segment, making the patient acutely ill again.
When the ileal disease involves the sigmoid
secondarily, it is not excluded by an ileotransverse colonic anastomosis. By exclud
ing the total area of the disease with an
ileostomy, the process can subside and the
secondarily involved adjacent structures can
easily and safely be resected with the pri
mary disease 10 weeks later. The ileostomy
can be taken down at the same time or sub
sequently.
If there is posterior perforation and ab
scess formation, or if there is a high degree
of obstruction because of the disease itself,
then total exclusion of the disease with no
attempt to remove it would be the operation
of choice. At a later late the disease can be
removed by an operation of lesser magni
tude than would have been necessary when
the disease was more active. So, do not
resect diseased bowel for retroperitoneal in
flammation or for posterior perforation. Do
not disturb the diseased bowel; just bypass
and exclude it and the associated abscess
completely. With exclusion bypass the dis
ease will subside, the abscess will resolve
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and the resection—in 10 weeks’ time—
will be a simpler procedure.
Do not resect short-term acute disease
simulating appendicitis. Leave the appendix
alone. Close the abdomen, consult the gas
troenterologist for non-operative manage
ment and prompt remission of the disease
usually follows. And here we are talking
about the patient who is acutely ill for a
few days and the surgeon operates because
signs of peritoneal irritation are present.
Instead of acute appendicitis he finds acute,
short-term Crohn’s disease. This is usually
resolved with medical management and does
not require resection. The reason for not
taking out the appendix is that iatrogenic
problems can occur. To a surgeon unini
tiated in Crohn’s disease, an appendix could
look quite innocent at the operating table
and he would remove it to prevent the de
velopment of an ordinary appendicitis at a
later date. He could easily fail to recognize
that the appendix is involved by Crohn’s
disease. It would be tempting to ascribe the
fat wrapping, the obliteration of the me
sentery-bowel angle, the segmental changes
in the serosa of the appendix, the presence
of lymphadenopathy in the mesoappendix,
and the prominent vessels of the cecum, to
the inflammatory reaction of acute appen
dicitis. To do an appendectomy under these
circumstances just because one has already
surgically exposed the area is to invite fistulization and other related problems.
An additional principle of management
is worth mentioning for duodenal involve
ment. We would ordinarily think that re
moval of the adjacent diseased segment and
closure of the hole in the duodenum would
be the appropriate form of management be
cause the duodenum is only secondarily
involved. But closure is hazardous and
faulty healing of the duodenum involved by
Crohn’s disease is the rule. Fistulization
often results and, of course, a duodenoileal
fistula or a duodenocutaneous fistula is
catastrophic in the presence of a fresh ileo
colic anastomosis. A much safer method of
managing such a problem is to resect the
disease and make an ileocolonic anasto
mosis, but instead of attempting to close
the duodenum, open the jejunum and make
a three-layer anastomosis with the duodenal
opening. This provides a large lumen for
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the duodenum, with well-vascularized tissue
at the defect. It decompresses the duodenum
as long as necessary and it does not divert
the intestinal contents permanently. Healing
is assured in an area previously involved by
inflammatory disease.
Finally, I would like to leave you with a
very useful clinical observation for which we
have as yet no explanation. We have found,
through the management of many patients
with Crohn’s disease with problems such as
we have reviewed, that ACTH, but not
prednisone or cortisone, seems to protect
and assure a more proper healing of an
anastomosis after a resection for Crohn’s

disease, even when there are subtle changes
indicative of the presence of Crohn’s dis
ease at the site of anastomosis. On the basis
of our experience to date, I recommend that
you give 40 units of ACTH, intramuscularly
or intravenously, daily in the postoperative
period. This seems to ensure proper healing
of the anastomosis.
Through the application of principles such
as these, surgical care becomes— as is med
ical care— a phase in the on-going manage
ment of the patient afflicted with Crohn’s
disease. And the surgeon and the internist
become participants in a continuing team
acting for the overall welfare of the patient.

RECURRENT CROHN’S DISEASE
F. T. de DOMBAL
C ro h n ’s disease, as you know, presents a
major problem, that of recurrence, which
hangs over every patient who has had sur
gery for this disease. For while one can give
the patient with ulcerative colitis a reason
able guarantee that the disease will not
recur, no such assurance can be given the
patient with Crohn’s disease.
Fig. 1 gives a representative statement of
the problem from a number of series. The
reported overall recurrence rates after sur
gery for Crohn’s disease vary from 3% to
62% . However, if there is one major point

NUGENT
1973

SCHOFIELD
1965

that I would like to make, it is that overall
recurrence rates are completely meaningless
in the context of Crohn’s disease, and I will
present some evidence that will, I hope,
demonstrate this point.
First of all, if we consider the primary
operation performed for Crohn’s disease we
find that in our hands (in Leeds, England)
the recurrence rate varies with the type of
operation, from 60% for small bowel re
section alone through 40% for small bowel
resection and right hemicolectomy, coming
right down to 10% to 15% after proctoco-
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Fig. 1.—Recurrence rates of Crohn’s disease as reported from various series. (Reproduced by per
mission from de D ombal FT: Results of surgical treatment for Crohn’s disease. Br J Surg 59: 826,
1972.)
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lectomy. Therefore, it first appears that the
recurrence rate depends on the type of op
eration which, in turn, often reflects the
site of disease. Second, the recurrence rate
after the initial operation depends upon the
age of the patient at the time of the first
operation. In our own patients, in the second
decade of life the recurrence rate is 52%
and it progressively drops to reach the low
level of 7% for patients operated on be
tween the ages of 60 and 70. Another find
ing is that the recurrence rate depends on
the duration of the disease. Cumulative
statistics for 170 patients with small and
large bowel disease illustrate this relation
ship (Fig. 2). One notes two peaks of high
recurrence, one relating to very short- and
the other to long-lasting disease.
This biphasic feature of the recurrence
rate in relation to time is also seen in Fig. 3
which shows the cumulative recurrence rate
following initial surgery. The risk of recur-
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rence is highest in the immediate post
operative period and again 10 to 15 years
later. We have also observed (compare
Figs. 2 and 3) that the patients who under
went surgery early in the course of their
disease tended to have an early recurrence,
while the patients who had their operation
later on (let us say after 20 years of medical
management) tended to have their recur
rence late. I do not want to complicate the
issue after having agreed that we really do
not know what Crohn’s disease is! But there
is evidence to suggest that there may be (a)
one type of Crohn’s disease which presents
early, comes to surgery early and recurs
early after operation and (b) another more
benign type which presents late, comes to
surgery late and recurs late.
It is also worth noting that in our series
a reoperation for recurrence was not neces
sarily a disaster. After one operation the
risk of further surgery is 34%, after two
operations the risk of a third is only 20%
and, in our few patients with three opera
tions, the risk of a fourth is about 30%.
Finally, I would like to attempt to answer
the question — does it really matter
whether postoperative recurrence occurs
early or late? I think it does. As you can see
from Fig. 4, in the group of patients in
whom the disease recurred early, 17%

of Crohn’s disease.

Fig. 3.—Cumulative recurrence rates in small
and large bowel disease. (Reproduced by permis
sion from de D ombal FT, Burton T, G oligher
JC: Recurrence of Crohn’s disease after primary
excisional surgery. Gut 12: 519, 1971.)

EARLY
RECURRENCE
(18 pati*nf t )

LATE
RECURRENCE
(33pati*n**)

Fig. 4.—Comparison of results from early and
late recurrence of the disease.
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eventually died, and at the time of the
review 45% of the survivors were, in one
way or another, dissatisfied with the out
come of their management. On the other
hand the late recurrence, which occurs from
five to 10 years after the initial operation,
is by no means a disaster. The overall
mortality in this “late” group was 5% and
when reviewed 95% of the survivors were
in good health and were satisfied with the
outcome of their treatment.
In summary I would like to underline two
points about recurring Crohn’s disease. First
of all, recurrence rates have been quoted in
a vastly different fashion around the world,
primarily I think, because of a lack of
definition of what recurrence is and also
because of failure to apply the actuarial
methods that we have been using in our own
statistics. Secondly, I think there are two
types of postoperative recurrence. While a
recurrence taking place one or two years
after surgery carries an excessively high
morbidity and an appreciable mortality, re
currence which appears five to 10 years
after an operation has a much more favour
able prognosis, albeit after further resection.
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ULCERATIVE COLITIS
ETIOLOGY AND EPIDEMIOLOGY OF ULCERATIVE COLITIS
R. J. SPENCER

So that all the contributions can be ade
quately presented, I am limiting my own to
only the most essential points.
It was once believed that ulcerative co
litis was primarily a disease of Jewish
people, that is, the incidence in Jewish
people was higher than in the non-Jewish
population. Current articles have indicated
that this is not true. However, Mendelhoff
found a slightly increased incidence of
ulcerative colitis in the Jewish population of
Baltimore. It is interesting that this was not
the case in the Jewish people who lived
beyond the strict confines of the metropoli
tan area and it is therefore suggested that
the condition may be a disease of urbaniza
tion. Our findings in Rochester, Minnesota,
have been somewhat similar but our do
cumentation is not complete.
Table I shows the annual incidence of
ulcerative colitis in the Rochester popula
tion. Note that, unlike any of the other po
pulations that have been reported, in Ro
chester we find a slightly increased incidence
in males. The annual incidence of the dis
ease is within the generally reported range.
In Table II the death rate of the disease in
Rochester is seen to be comparable to that
reported elsewhere. This seems to indicate
that the disease is unrelenting and, regard
less of the type of treatment, the same rate
of survival can be predicted. I would like,
humbly, to offer you my own theory of the
etiology of this disease.
T able I.—Annual I ncidence
Age
(years)
0 - 9 ..........................................................
10 - 19.........................................................
20 - 2 9 ..........................................................
30 - 3 9 .........................................................
40 - 4 9 .........................................................
50 - 59 .........................................................
60 - 6 9 .........................................................
Over 7 0 ........................................................
T otal............................................................

of

I feel that it is an immunologic disease, if
not in etiology at least in its pathogenesis.
The uncommitted lymphocytes, when ex
posed to an antigen, become large lympho
cytes. The large lymphocytes then can
pass on the information to a plasma
cell to produce an antibody, or to a
small immunologic lymphocyte which is the
mediator of the delayed hypersensitivity
reaction. We feel that this is the etiology or
perpetuator of ulcerative colitis. I think that
we have demonstrated quite well in lab
oratory tests, as shown in Fig. 1, that the
survival rate of colonic epithelium in a tis
sue culture exposed to lymphocytes from a
patient with ulcerative colitis is markedly
reduced. The control normal lymphocytes
do not demonstrate this capacity. Now, if
TABLE II.—A verage Annual D eath R ate from
U lcerative C olitis in R ochester per 100,000
C ompared with that R eported E lsewhere
Death rale
per 100,000
Rochester, Minnesota, 1935-1964
Acheson, 1960
U.S.A., 1952-1956 .....................
Canada, 1952-1957 ....................
England and Wales, 1953-1955
Evans and Acheson, 1965
Oxford, England, 1951-1960...
Mosbech, 1960
Denmark, 1951-1959 ................
Wigley and MacLaurin, 1962
Wellington, New Zealand,
1954-1958 ................................

U lcerative C olitis
No. o]
men
4
4
17
10
6
9
3
1
54

No. of
women
1
3
18
13
4
6
6
3
54

per

100,000

in

0.40
0.47
0.49
0.85
0.70
0.60
0.90

R ochester

Total

Total incidence per
100,000*

5
7
35
23
10
15
9
4
108

3
5
21
17
9
17
14
8
11.7

*Male, 13.2, female 10.5, age-adjusted rate 11.6 (adjusted to United States 1950 total white population).
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we use the sera from patients with ulcerative
colitis we find that there is no change in
the cell survival in tissue culture. There
fore, the factor concerned seems to be
a cellular factor. When colonic epithelial
cells are incubated with a hash made from
lymphocytes obtained from patients with
ulcerative colitis, they also demonstrate a
decreased survival rate. This phenomenon
occurs not only in ulcerative colitis, but
also in granulomatous colitis. After co
lectomy in patients with either chronic
ulcerative colitis or Crohn’s disease, we find
that the lymphocytes become essentially
normal again in that the cytotoxicity previ
ously observed disappears rather rapidly.
This reversion to normal could be claimed
as the weakest point in our theory, for the
lymphocytes should maintain their cytotoxic
capacity. But we feel that because these
lymphocytes are no longer challenged their
cytotoxic capacity disappears.
To summarize the etiology of ulcerative
0
I
2
3
4
6
colitis,
I simply maintain that it is an im
HOURS
munologic
of delayed hypersensit
Fig. 1.—Effect of lymphocytes from a patient ivity as we disease
have
demonstrated
by in vitro
with ulcerative colitis on autologous colon cell
viability.
methods of investigation.
OO >
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CLINICAL FEATURES, PATHOPHYSIOLOGY, COMPLICATIONS AND
ENDOSCOPIC FINDINGS IN ULCERATIVE COLITIS
G. J. DEVROEDE
T he initial symptom of ulcerative colitis is patients the disease has remissions. In a

bloody diarrhea, usually without abdominal
pain, but constipation may be a feature of
distal colitis in which the patients pass
bloody mucus between formed stools. Emo
tional trauma, anxiety and depression are
not prominent features reported in re
trospective studies. Compared with patients
suffering from irritable colon and with
normal controls, patients with ulcerative
colitis have significantly fewer antecedents
and a lower stress index. Finally, as tested
by the Minnesota Multiphasic Personality
Inventory (MMPI test), patients with ulcer
ative colitis are less neurotic as a group than
patients with psychosomatic disease and, in
particular, those with irritable colon. There
fore, there is no evidence for a psycho
somatic basis for ulcerative colitis. In most

1963 survey the Leeds group found that
80% of their patients were leading a normal
life at that time. Many patients with mild
or moderate colitis have no demonstrable
physical signs. Even in the acutely ill,
clinical signs may be difficult to interpret.
The Leeds group demonstrated that clini
cians had no difficulty in assessing the
presence and severity of abdominal tender
ness and distension, but they were less con
sistent in evaluating pallor, anemia, dehydra
tion, guarding and rigidity.
At endoscopy (Fig. 1) normal subjects
have a normal vascular pattern without con
tact bleeding. In ulcerative colitis, the vas
cular pattern disappears. Contact bleeding
is present in mild colitis, free bleeding
in moderate colitis and muco-pus is
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Fig. 1.—(a) Normal mucosa. The vascular pattern is clearly visible; there is no erythema and there
are no petechiae. (b) Mild ulcerative colitis. The vascular pattern is not evident; there is
practically no free bleeding. At biopsy there was severe atypia with numerous mitoses, (c) Mild
ulcerative colitis with carcinoma in situ at biopsy. A healed granular lesion of the mucosa is present
which is characteristic o f the disease, (d) A more active form o f the disease. Free bleeding is present;
the healed granular lesion o f the mucosa is still recognizable, (e) Moderate ulcerative colitis. There is
free bleeding and the vascular pattern is absent. The healed granular mucosal lesion is no longer
evident, (f) This mucosa is very fragile so that a slight touch with a cotton-tipped applicator induces
profuse bleeding (same area as e). (g) Severe ulcerative colitis showing diffuse involvement with massive
free bleeding and muco-pus. (h) Another case of severe ulcerative colitis. There are loss o f vascular
pattern, diffuse involvement, free bleeding and pseudopolyps, (i) The reversibility o f these lesions may be
striking by gross examination although microscopic abnormalities persist. The pseudopolyps seen in (h)
have been epithelialized and some vessels are visible, since this patient’s clinical condition markedly
improved. (Published by courtesy o f the Olympus Corporation o f Canada, G. D. Searle & Co. of
Canada Ltd. and the ACM I Company.)
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passed in severe colitis, sometimes as
sociated with edema, pseudopolyps and
strictures. There is good observer agree
ment in distinguishing normal and abnormal
proctoscopic findings, the presence or ab
sence of a vascular pattern, contact bleeding
and edema. The difficulties lie with the very
mild and the very severe forms of the dis
ease. Thus, in patients with very mild colitis,
the pathologist may report mild inflamma
tion while the gross appearance is normal.
Unfortunately, a similar degree of inflam
mation may be reported in patients without
colitis. There is also difficulty in assessing
the severity of colitis.
The reported percentage of patients with
distal proctitis who later develop total
colitis ranges from 6% to 30% . Increasing
use of colonoscopy is beginning to show that
patients who have limited distal colitis as
indicated by barium enema may, in fact,
have more extensive disease. Another pro
blem is the difficulty in correlating histo
logical and endoscopic findings in mild co
litis. Thus, the question of proximal pro
gression is not settled.
Colonic function is impaired in ulcerative
colitis. Net absorption of sodium is lower
than in controls. This is the result of a de
creased insorption (the movement from the
lumen to the blood) and an increased exorption (the leakage from the blood to the
lumen). This is accompanied by a decrease
in the potential difference that exists be
tween the mucosa and the serosa, the de
crease being more marked in patients with
severe colitis than in patients in quiescent
stages. In addition to loss of fluid and elec-
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trolytes, nitrogen and blood are also lost. If
the fecal output is measured in normal sub
jects and before and after proctocolectomy
in ulcerative colitis, it will be found that
after proctocolectomy patients still lose
more water and sodium than normal sub
jects. However, they no longer lose nitro
gen and this is the major metabolic benefit
provided by proctocolectomy.
There are local and systemic complica
tions of ulcerative colitis. In our experience
the incidence of anorectal complications is
much lower than what has been reported
from Leeds (Table I). Pseudopolyps occur
in severe colitis owing to edema and
inflammation and when the colitis subsides
they may coexist with a normal vascular
pattern. Strictures may occur early in the
course of the disease and must be distin
guished from carcinoma and Crohn’s
disease. Perforation occurs in 6% of the first
attacks and in 3% of subsequent attacks;
the incidence is greater in severe colitis and
total colitis. Cancer risk is a major prob
lem in chronic ulcerative colitis. About 20%
of the patients develop cancer for each
decade after the first 10 years of disease.
The age of the patient at the time of onset
does not affect cancer risk and the risk is
much greater than in patients with granu
lomatous colitis. It is at its highest in
patients who have total colitis. There is no
published report of a cancer complicating
colitis which has remained limited to the
rectum. The exact incidence of acute dila
tation of the colon in ulcerative colitis is un-

TABLE I.—L ocal C omplications of Ulcerative
C olitis (Leeds 1963)
Percentage o f
465 cases

C o m p lica tio n

Anorectal complications:
abscess
fistula-in-ano
rectovaginal fistula
fissure-in-ano
Pseudopolyposis
Stricture
Perforation
Carcinoma
Dilatation: of diseased colon
above diseased colon
Massive hemorrhage

25.9
6
5.4
2.2
12.3
12.5
11.2
2.8
1.7
3.0
0.4
1.5

Fig. 2.—Transverse colon diameter on a plain
film of the abdomen.
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known because the definition of toxic megacolon is based on radiological examination
and the normal values for colonic dia
meter have been determined only recently.
The normal diameter of the transverse co
lon never exceeds 5.5 cm and in colitis with
toxic dilatation it can reach as high as 15
cm (Fig. 2). Another feature of the mega
colon in ulcerative colitis is that in contrast
to normal subjects and patients with un
complicated colitis, the transverse colon is
wider than the ascending colon. The clinical
course of acute dilatation is unpredictable
but it carries a very high mortality. Factors
known to precipitate the development of a
megacolon are barium enemas, hypokalemia,
opiates and anticholinergics.
Systemic complications of colitis are
numerous. Ninety percent of liver biopsies
in ulcerative colitis are abnormal and
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changes range from mild inflammation to
cirrhosis, with the majority showing fatty
infiltration and focal necrosis. In the biliary
tract, pericholangitis, sclerosing cholangitis
and carcinoma of the bile ducts may occur.
Finally, arthritis and ankylosing spondylitis
are frequent. Arthritis occurs in 11% of
patients with a long-standing history of co
litis. It is usually monoarticular, sym
metrical, involves the knees or ankles and
is usually cured by colectomy. In contrast,
ankylosing spondylitis does not heal after
surgery. Its incidence is high, especially in
males, and the condition has a familial ten
dency. Eighteen percent of patients with
ulcerative colitis have sacroiliac arthritis
compared with 4% in the general popula
tion, and their relatives also have an in
creased incidence if the probands have
severe colitis and total colitis.

HISTOPATHOLOGY OF CHRONIC ULCERATIVE COLITIS
G. SANCHEZ-CASIS

course of ulcerative colitis is typically
one of remissions and exacerbations, a fact
that is reflected in the range of histological
appearances observed in biopsy material.
Therefore arbitrary divisions are necessary
based on specific variations in the histopathology. For this reason I shall consider
three separate phases of the disease: (1)
acute; (2) quiescent; (3) chronic persistent.
In the acute phase the more important
changes are edema, congestion, infiltration
with polymorphonuclear leukocytes with
reduction of mucus production and forma
tion of characteristically superficial crypt
abscesses, and a total participation of the
colonic glands in the disease process (Fig.
1). Usually, in this phase, the disease is well
localized to the mucosa; however, in very
acute cases the submucosa may show edema
and dilatation of the capillaries.
The quiescent or inactive phase is cha
racterized by an attempt at restitution, but
residual changes such as glandular dis
organization, abnormally small or short
glands, fibrosis of the lamina propria and
T he

hypertrophy of the tunica muscularis mu
cosae are usually found (Fig. 2).

Fig. 1.—Rectal biopsy showing the acute phase
of ulcerative colitis. Note the marked inflamma
tory infiltrate, crypt abscesses and reduction of
mucus production with degeneration of some of
the glands.
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Features of the chronic persistent phase
are persistent ulceration, infiltration with
polymorphonuclear leukocytes, crypt ab
scesses and, more significantly, the presence
of psudopolyps and precancerous changes.
The pseudopolyps consist of edematous
granulation tissue and persistent inflam
matory crypt abscesses. Another sign o f
long-standing disease is Paneth’s cell meta
plasia with excessive mucus production by
the mucosal glands.
Finally, in the stenotic segment of a long
standing case of chronic ulcerative colitis, a
precancerous stage with a wide range of
dysplasia may be present (Fig. 3) before the
stage of frank carcinoma in situ is reached.
Severe atypia with adenocarcinoma may
also develop (Fig. 4).
In summary, the degeneration of the
crypts with participation of the total mucosa
in the acute phase and the precancerous or
dysplastic changes in the chronic persistent
phase are the most characteristic diagnostic
features of chronic ulcerative colitis. Other
important features include a “healed gra
nular” mucosa, a persisting inflammatory
reaction and an irregular glandular pattern;
the absence of fissures is a particularly
valuable sign in differentiating the early
phase of chronic ulcerative colitis from
Crohn’s disease.

Fig. 2.—Rectal biopsy showing the quiescent
phase. Note the irregular mucosal pattern with a
decrease in the number and size of the glands.
Note also the absence of inflammation.
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Fig. 3.—Rectal biopsy demonstrating chronic
persistent disease. Note the colonic glands with
disorganization, atypia and dysplastic changes. A
marked degree of inflammation persists.

Fig. 4.—Rectal biopsy shows chronic persistent
disease. Note the complete disorganization of the
glands and the presence of an undifferentiated
adenocarcinoma in a case of long-standing ulcera
tive colitis.
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RADIOLOGY IN ULCERATIVE COLITIS
H. SUPELANO-GUEVARA

T he classical radiological signs of ulcerative
colitis were well reviewed by Marshak and
Lindner in 1966. More recently Margulis
et al and Stanley et al gave detailed descrip
tions of the typical radiological features per
mitting identification of ulcerative and
granulomatous colitis (Table I). In spite of
these typical signs, however, it may be ex
tremely difficult to distinguish these two
types of colitis. Other conditions must also
often be considered in the differential diag
nosis, for example amebiasis, tuberculosis,
ischemic colitis and diverticulitis.
Radiographic examination of the colon
by barium enema generally demonstrates
the gross pathologic findings (Fig. 1).
One of the earliest and most acute condi
tions in inflammatory disease is edema. It
is manifested by a coarse mucosal pattern
(Figs. 2 and 3) and separated folds which
are particularly well seen on the post-eva
cuation film. On these films the haustral
folds are seen to be wide and shallow. This
finding is encountered in all types of in
flammatory disease.
Superficial ulcerations are typically seen
in the rectosigmoid colon but may appear
throughout the entire colon. As the disease
progresses haustrations tend to disappear

TABLE I.—C omparison

of the

and spasm and irritability of the colon are
seen (Fig. 4). Eventually shortening and
rigidity of the bowel develop, producing a
stove-pipe appearance. Pseudopolyps are
likely to occur at this stage.

Fig. 1.—The transverse colon shows a moderate
degree of ulceration along the upper border.

R adiographic F indings “T ypical”
G ranulomatous C olitis

Ulcerative colitis

1. Total involvement of colon
2. Rectum involved in continuity with descend
ing colon if colonic involvement is complete
3. Concentric, circumferential involvement
4. Shallow or “collar-button” ulcers
5. Pseudopolyps in active disease
6. No fistulas or abscesses
7. Shortening of colon without localized
strictures
8. Gaping ileocecal valve
9. Toxic megacolon prevalent
10. Significant increase in incidence of cancer
with long-standing ulcerative colitis

of

U lcerative C olitis

and

Granulomatous colitis

1. Segmental or focal involvement (skip lesions)
of colon
2. Ascending colon most often involved
3. Non-circumferential involvement
4. Deep ulcers (greater than 2 mm) and
fissures perpendicular to bowel lumen
5. Longitudinal ulcers ofter creating “cobble
stone” effect
6. Frequent fistulas or abscesses
7. Frequent strictures
8. Thickened ileocecal valve criss-crossed by
ileocecal fistulas
9. Toxic megacolon less frequent
10. Cancer incidence less markedly increased
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Collar-button ulcers have been described
as occurring more commonly with ulcerative
colitis but according to Margulis et al the
incidence of this type of ulcer is almost
identical in both ulcerative and granulo
matous colitis.
Deep ulcers which penetrate beyond the
mucosal membrane (2 mm or more as meas
ured on the radiograph) constitute evidence
of a more severe reaction of the colonic
wall.
Fistulas and abscesses result from deep

Fig. 2.—Spot film of the descending colon show
ing a fuzziness of the mucosal outline with nu
merous tiny ulcerations.

Fig. 3.—Post-evacuation film. The mucosal folds
are hazy and thickened in a symmetrical fashion.
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ulcers that penetrate beyond the limits of
the colon. Their presence indicates, particu
larly in granulomatous colitis, severe and
invasive disease. Perforations following
ischemic colitis have been reported. Ame
biasis, salmonellosis, actinomycosis and tu
berculosis all can cause sinuses and fistulas.
Toxic megacolon is typically associated
with a fulminating course in ulcerative colitis
but it is now known to occur in Crohn’s
disease as well as in amebiasis and ischemic
colitis. Occasionally the development of
megacolon is precipitated by the use of a
barium enema.
The appearance of the bowel wall is of
greater significance than increased calibre
of a portion of the colon. In the segments
maximally involved the normal haustral pat
tern is completely absent. In less affected
portions the interhaustral septa may persist
but appear unusually thick and may be in
complete or wavy in contour.
Despite the marked distension the bowel
wall does not appear to be under great pres
sure. The dilated segments tend to maintain
a cylindrical or tubular configuration with
rounded, sometimes tapering, ends. The
cause of so-called toxic segmental dilatation
is unknown but is related to acute inflam
matory changes affecting all coats of the
bowel wall, often with necrosis and perfora
tion.

Fig. 4.—Minimal narrowing and rigidity of the
colon. The haustral markings are absent or irre
gular in the distal transverse and descending colon.
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MEDICAL MANAGEMENT OF ULCERATIVE COLITIS
JOHN E. LENNARD-JONES

I am glad that the* subject that has been
assigned to me is the “management” of
colitis and not just its treatment because
this is a condition that has to be managed,
and we do not have a medical cure, al
though there is a surgical cure.
The clinician may first see the patient
during an acute attack of colitis and then
his first job is to assess the severity of the
disease. There are some useful guides in
assessing severity, but suffice it to say at
the moment that it depends largely on the
extent of the colon involved and also the
depth to which the mucosa is ulcerated.
It also depends on the physique of the pa
tient and, in particular, his age. Having
assessed the severity of the disease, one has
to decide on the treatment. There are situ
ations in which surgical treatment is the
immediate and initial form of therapy, and
the use of medical therapy such as cortico
steroids is contraindicated. I will devote most
of my time to medical management. One
may see a patient during remission of the
colitis. Here, one has to consider the prog
nosis for that patient, depending on the
nature of his disease up to that time. One
has to try, if one decides to continue with
medical treatment, to prevent relapse, but
if a relapse occurs, to treat it energetically
and quickly, the emphasis being on “quick
ly”. It is also the clinician’s job to prevent
cancer, and this will be dealt with elsewhere
in this symposium.
Sometimes one sees a patient with chro
nic, persistent symptoms, where the obvious
question is: Is the treatment for that patient
optimal? I propose to spend most of my
time on the acute attack and medical treat
ment, but I will mention the matter of pre
venting relapse.
The treatment of colitis cannot be stand
ardized, but one can make some generali
zations. Quite a high proportion of patients
with colitis have inflammation restricted to
the distal colon, namely the rectosigmoid
and perhaps the lower descending colon.
These patients generally do not have any

systemic upset such as fever, loss of appe
tite, loss of weight, or metabolic distur
bances. One can think of treatment under
several headings. There are general meas
ures, replacement therapy, drug therapy and
surgical treatment. Patients with distal dis
ease and no systemic upset can usually lead
a normal life and do not require admission
to hospital. There is some evidence that a
few benefit from a milk-free diet but I only
prescribe it for those for whom it is defi
nitely helpful. These patients bleed and the
only replacement therapy likely to be needed
is iron.
Drug therapy consists mainly of salicylazosulfapyridine (Salazopyrin) and topical
corticosteroids. The evidence for the use of
Salazopyrin in colitis is reasonably well
established. Fig. 1 shows the symptomatic
response after three weeks in a controlled
trial done some years ago. The first group
of patients was treated with Salazopyrin in
an initial dose of 4 g daily, subsequently
reduced to 2 g daily. Patients receiving an
inert tablet in a double-blind manner form
the group on the right side of Fig. 1.
Notice that more of the patients receiving
Salazopyrin were symptom-free or improved
than patients who were given the control
tablet, most of whom were unchanged. The
patients shown in black had to stop the

Fig. 1.—Response of colitis to salicylazosulfapyridine.
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treatment because of side effects. Often
gastrointestinal side effects such as nausea
can be helped by the use of enteric-coated
tablets but these are ineffective in prevent
ing other side effects such as headache,
malaise, and hematological disorders. The
frequency of these side effects depends very
much on the dose used.
Corticosteroids can be given in supposi
tory form if the upper limit of the disease
can be seen, that is if only the lower 10 cm
of the rectum is involved. Otherwise the
steroid has to be given as a retention enema.
Retention enemas can be given as a drip,
by means of a disposable pack or using a
plastic bladder syringe and rubber catheter.
The patient can make up his own enemas
from tablets and solution. It is an advan
tage if one can alter the volume of the
enema and the concentration of the steroid.
Fig. 2 shows data from four patients who
were given retention enemas of different
volume, 50 ml, 100 ml, 150 ml and 200
ml. The area of colon in contact with the
solution was estimated by adding a little
barium to the therapeutic enema. A small
enema of 50 ml usually stayed in the rec
tum and sigmoid colon; 100 ml ascended
a variable distance, in one patient nearly
to the hepatic flexure but in another re
maining in the rectosigmoid. As you might
expect, 150 ml tended to go a little further

SO

wo

150

200

Fig- 2.—Area of colon in contact with therapeutic
enemas of differing volumes.
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but in one patient did not go any higher
than did 50 ml. The lesson is that if one
is going to use topical steroids, one must
cover the diseased area of colon with the
solution, and the only way of finding out
if you are doing so in a particular patient
is to add a little barium to the solution
(Swarbrick et al, 1974).
Ulcerative colitis associated with some
systemic upset, such as fever, weight loss
and metabolic disturbances is, of course,
usually a more extensive disease. These pa
tients often need admission to hospital for
replacement therapy, which is important
and is sometimes neglected. Since large ni
trogen losses can occur in ulcerative colitis,
the emphasis is now on a high protein,
nutritious diet containing a large number
of calories, rather than a low-residue diet.
A potassium supplement is often required
because potassium is lost in diarrhea and
corticosteroids cause a loss of potassium
from the kidney. To rely on topical cortico
steroids for the treatment of extensive co
litis is, in my opinion, a mistake. These
patients almost always require systemic
steroids in the form of oral prednisolone
or an equivalent drug, perhaps supple
mented by topical steroids. They may also
be helped by corticotrophin or ACTH, and
I was interested by Dr. Weakley’s comments
on ACTH.
What dose of steroids should one use?
Fig. 3 shows results from a trial with three
groups of 20 patients, one group given 60
mg of prednisone, another group 40 mg

Fig. 3.—Number of patients in remission at
different times after treatment with prednisone.
(Reproduced from B aron J H , C o n n e l l A M ,
K a naghinis TG, et al: Out-patient treatment of
ulcerative colitis. Comparison between three doses
of oral prednisone. Br M ed J 2: 441, 1962.)
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and a third group 20 mg daily. The figure may be severe because there is a brisk sys
shows the number of patients going into temic inflammatory reaction with high fever
remission over a specified period of time. and perhaps associated complications such
Note that with the bigger dose more pa as arthritis. It is this group of patients who
tients went into remission, but there was may do well with either intravenous cortico
an increase in side effects when the dose steroids or ACTH. It may be severe because
was increased from 40 mg to 60 mg daily. there is a grave metabolic disturbance with
For this reason my own practice is to use fluid and electrolyte imbalance or, more
prednisolone, 40 mg daily, as the optimal commonly, protein loss with loss of muscle
dose to start with, and I think that it is bulk and emaciation. The treatment of pa
a mistake to start with smaller doses as tients in this group is, of course, along
metabolic lines. Or it may be severe be
these are often ineffective.
Fig. 4 shows comparison of the effects of cause the mucosa is deeply ulcerated and
a trial of cortisone 200 mg daily and cor- the inflammation has penetrated into the
ticotrophin 80 units daily (Truelove and muscle, causing loss of tone and dilatation,
Witts, 1959). You will observe that the or even to the peritoneum, causing perfo
proportion that went into remission was ration. I regard the condition in this group
greater with corticotrophin than with cor of patients as a surgical emergency and not
tisone. We have had a number of patients to be treated with corticosteroids.
If remission of the colitis is achieved,
who failed to respond to the administration
and
this occurs in at least two-thirds of the
of prednisolone but responded to ACTH.
patients
with distal colitis although less
We have tried to find out why this is -so.
Is it a quantitative effect or is it a quali commonly in patients with more severe
tative effect of corticotrophin which causes forms of colitis, the major question is how
secretion of other steroids? We do not to keep such a patient well. There is cer
know, but ACTH is a useful drug and is tain advice one can give to the patient.
worth bearing in mind for the patient with Infection may bring about relapse and
therefore he must be careful, for instance,
a more severe form of ulcerative colitis.
I will now discuss the treatment of very when travelling abroad. I think that broadsevere colitis. The problem here is that the No ot Patients
colitis may be severe in different ways. It
R E L APSEC

a .c t .h .
Group

C o r 11 sone
Group

E ffect o f T re a tm e n t-W h o le Senes
Fig. 4 .—Comparison of effects of ACTH and
cortisone in bringing about remission of colitis.

Months

from

start

ot
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Fig. 5 .—Comparison of relapse rates in patients
initially in remission and receiving salicylazosulfapyridine or placebo.
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spectram antibiotics can precipitate a re
lapse, and he needs to be warned of this
danger. There are also long-term drug treat
ments, and Fig. 5 shows a comparison of
the ratios of relapse over a period of one
year in patients initially in remission and
receiving either Salazopyrin or placebo tab
lets (Misiewicz et al, 1965). These results
have since been confirmed and extended
in Oxford (Dissanayake and Truelove,
1973) and I believe there are good grounds
for giving Salazopyrin indefinitely to the
patient with ulcerative colitis in remission
who can take this drug without trouble.
In a similar trial over a period of six months
the proportion of patients given either pred
nisone 15 mg a day or a control tablet,
whose disease recurred, was the same. This
dose of prednisone therefore did not reduce
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the relapse rate (Lennard-Jones et al, 1965).
In my opinion, unlike Crohn’s disease,
there is little or no indication for long-term
low-dose steroid therapy in ulcerative co
litis. This type of therapy leads to problems
and it is probably of no benefit.
Lastly, I have said that the job of the
clinician is to prevent cancer. We will hear
more about this, but I consider the follow
ing as the high risk factors: extensive co
litis, a history of over 10 years’ duration,
onset in childhood, and continuous symp
toms rather than intermittent disease with
periods of remission. One must be aware
that patients in remission with these clinical
features are at a risk from cancer (LennardJones et al, 1974). One must bear these
factors in mind as one continues managing
the patient in remission.

PROGNOSIS OF ULCERATIVE COLITIS AFTER MEDICAL TREATMENT
JAMES P. McMANUS

L

t— -

We have endeavoured to learn more about
the course and outcome of patients with
ulcerative colitis from a retrospective study
of 399 patients treated in our unit from
1950 to 1967. Of these patients, half pre
sented during their initial attack and half
were first seen in a relapse. The assessment
of the severity of the colitis was based on
objective criteria using a scoring procedure
devised by a team of experienced clinicians
and utilizing such variables as original tem
perature readings, the number of bowel
movements, and the sedimentation rate. The
patients, on the basis of their score, were
then classified as severely, moderately, or
mildly affected by colitis.
The characteristics of the population
studied can be summarized as follows: 80%
of our patients were between 20 and 50
years of age; perhaps not surprisingly older
patients tended to appear in their first at
tack, whereas younger patients were more
likely to be seen in relapse. No significant
relation could be found between the sev
erity of the disease and the patient’s state
during the attack. Furthermore, first attacks
tended to have a sudden onset, whereas the

patient seen with a relapse tended to give
a history of a more gradual onset of his
bout of colitis.
Since 1957, the number of referrals to
the unit has tended to remain fairly con
stant, averaging about 25 patients annually,
so from our experience there seems to be
no increase in the incidence of colitis in
the southeast of Scotland.
We considered the short- and long-term
outcomes without any specific reference to
mode of treatment, but it can be assumed
that all patients had what was the best ac
cepted means of treatment available at that
particular time. Consideration of the rela
tion of the short-term outcome to the sever
ity of the initial attack shows that the clas
sification of severity seems to be fairly
accurate since only one patient whom we
judged to be only mildly or moderately ill
died from his disease (Fig. 1). As Dr.
Lennard-Jones has mentioned, age is of
some importance and we found an increas
ing mortality rate with age particularly in
patients over the age of 50, who had a very
appreciable mortality rate of 35% . The
deaths, with the one exception mentioned,
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occurred in patients who were classified as
severely ill.
The duration of the disease before refer
ral is also relevant. When the duration of
symptoms was less than three months, that
is, in patients with acute onset of ulcerative
colitis, the mortality rate was 34.1% . How
ever, at the other end of the spectrum, pa
tients with a long history of more than 10
years had a mortality of 37.5%.
When we consider the extent of the dis
ease we run into the difficulty of how this
may be determined. Colonoscopy was not
available in the years covered by our sur
vey, and we are the first to admit that
barium enema studies tend to underestimate
the extent of the disease. Generally we can
say that the patients with a normal barium
enema, that is, with their disease confined
to the rectum, tended to do very well. There
was no appreciable difference in the mor
tality rates of patients with colitis and pan
colitis as determined radiologically.
With respect to laboratory investigation,
suffice it to say that in patients with severe
ulcerative colitis there is an increased in
cidence of abnormalities in liver function,
of hypokalemia, of hypoalbuminemia, leu
kocytosis and anemia. As regards the local
and systemic complications, we have found
— and cannot satisfactorily explain— that
inflammatory polyps (which is probably a
better term than pseudopolyps) and fecal
stasis were associated with a more favour
able outcome than when either of these
features was absent provided the activity
of the colitis was of the same degree.

In patients who developed a toxic mega
colon we observed a mortality rate of 45% ,
and if perforation supervenes in these pa
tients the mortality rises to a staggering
75% .
With reference to the relapse rate and
mortality, we have failed to observe any
difference between left-sided colitis and
pancolitis, but we tended to operate much
more frequently on patients with pancolitis.
This may have altered our mortality fig
ures. The severity of the attack appeared
to be much more important than the extent
of the disease. A severe left-sided colitis
is more serious than moderately active dis
ease affecting the whole colon. Patients over
the age of 50 with severe colitis appeared
to be at great risk.
When we examine the long-term out
come, again over the age of 50 there is a
high total mortality. In those patients with
chronic continuous disease there is a higher
rate of surgical intervention. Of these pa
tients 82% were operated on, in contrast
to 30% of patients with only episodic
exacerbation of their disease. Patients with
chronic continuous disease also have a high
er mortality — 25% in our experience,
compared with 14% for patients with epi
sodic disease. The severity of the disease
in the first attack continues to influence
the long-term prognosis. In our series pa
tients with severe colitis had the highest
mortality rate, 32% ; in moderate colitis it
was 15% and the patients who initially
presented with mild colitis had a long-term
mortality rate of 4.5% . Thus the first at
tack is a very critical time and the subse
quent trend in mortality perhaps reflects

\4

v

V

V

V

369

79
RADICAL SURGERY

FURTHER ATTACK

MILD

i
YEAHS OF FO LLOW UP

Fig. 1.—Survival rate in patients with mild,
moderate and severe colitis in the first referred
attack.
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Fig. 2.—Results of long-term follow-up of 369
patients with ulcerative colitis.
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the inadequacy of present management.
The long-term follow-up of 369 patients
is shown in Fig. 2: 33 died and 79 had
radical surgery, leaving 257 patients at risk.
Of these, 158 had a further attack.
When we look at the pattern of the dis
ease in the subsequent attacks, we can sim
ply state that there was a positive correlation
between the severity of the first referred
attack and the subsequent attack. However,
there appears to be a trend towards im
provement. There was less tendency to
severe exacerbation in the long-term fol
low-up. When the progression of the dis
ease in further attacks is examined and
provided radiological methods are used—
and I should qualify this further by speci
fying a conventional barium enema—there
is a suggestion that the disease tends to
involve shorter lengths of the colon during
subsequent attacks. Patients with partial
involvement initially seem to show lesser
degrees of involvement, and patients seen
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initially with total involvement of the colon
show an apparent diminution of their dis
ease during the subsequent years.
To assess the morbidity from the disease
we have used the relapse rate and the hos
pital admission rate. Both rates, and the
mortality rate, correspond very closely for
patients seen in their first attack and those
first seen in a relapse. The highest degree
of morbidity and mortality occurred in pa
tients who were moderately ill. This again,
I think, is probably a reflection of our sur
gical aggressiveness, as patients severely ill
tended to be operated on earlier. The long
term survival rate for the entire group is
80% but this is markedly improved if the
patients did not require surgery. A very
interesting observation is that patients who
were submitted to operation continued to
suffer from an increased mortality in their
long-term follow-up. Therefore even sur
gery does not seem to be the complete
answer in the treatment of this condition.
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SURGICAL TREATMENT OF ULCERATIVE COLITIS
DONALD C. McILRATH

D r . L en n a rd -J ones has told us that the
physician manages the patient with chronic
ulcerative colitis, but the surgeon has the
opportunity to cure him. As a surgeon, I am
delighted to hear these comments because
any physician who holds these beliefs will
tend to refer the patient for appropriate sur
gical therapy at the optimal time during the
course of the disease. It is unfortunate, how
ever, that the surgeon often does not see the
patient at the optimal time. All too often the
patient is debilitated nutritionally or shows
signs of excessive administration of steroids
over an unbelievably long period of time.
The basic indications for surgery can be
considered as absolute— perforation, fistula,
malignant change and toxic megacolon—
or less definite— when there has been an
inadequate response to medical treatment.
Most delays in performing colectomy seem
to occur in patients to whom the last in
dication applies. It has been mentioned by
several participants that a dreaded com
plication of ulcerative colitis is the devel

opment of malignant change in the colon.
Fig. 1 shows a photograph of a resected
colon with three separate areas of adeno
carcinoma superimposed on chronic ulcer
ative colitis. It can be appreciated that there
is very little gross change associated with
these malignant growths and, consequently,
detection of the tumours was difficult. This
example is only one of the reasons why
early recognition of the development of ma
lignant change in the colon usually is de
layed. The need for proctocolectomy prior
to its onset is apparent.
The surgical treatment of patients with
chronic ulcerative colitis entails one of two
basic procedures. Total proctocolectomy
with permanent ileostomy is the common
procedure of choice. The alternative is ab
dominal colectomy and ileorectostomy. This
is possible when the rectum is free of dis
ease and a satisfactory long-term result can
be expected. Factors to be considered in the
selection of patients for abdominal colec
tomy and ileorectostomy can be listed as:
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(1) the long-term functional result expected;
(2) the risk of neoplasm; (3) the develop
ment of progressive proctitis; and (4) the risk
of the operation. The risk of malignant
change and ulceration developing in the re
tained rectum are the primary concerns asso
ciated with this procedure. Several other sur
gical procedures have been advocated for the
management of patients who develop the
complication of toxic megacolon. Some sur
geons have used ileostomy alone but, in my
opinion, this operation is inadequate because
it does not alter the basic disease process in
the colon which is the source of the patient’s
serious illness. For the same reason multiple
colostomies and ileostomy are not appeal
ing. I prefer to do abdominal colectomy or
proctocolectomy with ileostomy.
The modern ileostomy described initially
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by Warren and McKittrick and popularized
subsequently by Brooke and by Crile and
Turnbull has been used extensively during
the past 20 years. With this basic type of
ileostomy the incidence of stomal complica
tions and the frequency of revision have
been reduced markedly. Of current interest
is the ileal pouch procedure described by
Kock which offers the advantage of elimi
nating the need for a permanent appliance.
My colleagues and I have used this pouch in
a limited number of patients who underwent
proctocolectomy for chronic ulcerative coli
tis and we are in the process of evaluating
the early results. In my opinion a longer
period of follow-up will be necessary to
compare the advantages and disadvantages
of the Kock pouch with the well-known re
sults of the common type of ileostomy.

PROGNOSIS AFTER PROTOCOLECTOMY
F. T. de DOMBAL
T he complications and prognosis after
proctocolectomy can conveniently be di
vided into those of the short term and the
long term. Fig. 1 relates to the short-term
consequences and illustrates two points.
First, total proctocolectomy for ulcerative
colitis by no means always ensures a
straightforward recovery. We have listed
some of the complications such as delayed
healing of the abdominal wound or of the
perineum, other major complications such
as cardiovascular and pulmonary c o n d i
tions, and also postoperative hospital stay
of over four weeks. Therefore, proctocolec
tomy is not an operation to be undertaken
lightly.
Second, the complication rate, post
operative morbidity and mortality depend,
to a large extent, on whether the operation
was performed electively, as a matter of
urgency, or as an emergency procedure.
Actually these data relate to a survey pub
lished in 1966 by Watts et al, and in the last
10 years, in Leeds, the overall postoperative
mortality has fallen dramatically. The
mortality rate for each category has not

changed very much but, with the use of
°/o
Deiat Healing1^
100

Fig. 1.—Postoperative morbidity and mortality
after proctocolectomy for ulcerative colitis. (Re
produced by permission from W atts JM, de
D ombal FT, G oligher JC: Early results of sur
gery for ulcerative colitis. Br J Surg 53: 1005,
1966.)
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more timely surgery and also by cutting
down the time spent reaching a decision
about whether to operate on a patient with
severe colitis, we have transferred many of
our patients from a more urgent to a less
urgent category. All these facts are, in
my view, eloquent argument for using a
timely and safe elective operative procedure
rather than waiting for the patient to be
come desperately ill and then performing a
high-risk emergency operation.
Now, going on to long-term implications
and long-term prognosis, I would like, if I
may, to express surprise at the results shown
by Dr McManus. It is true that in Leeds we
may be guilty of observer variation in many
fields of medicine, but it is difficult to have
very much observer variation when you are
dealing with the patient’s death. Either the
patient is alive, or he is dead. And I have
to say that most of the patients in our series
are alive (Fig. 2). This excludes, I must
admit, all incidental and unrelated deaths
(which in our series were comparable to the
death rate of a matched sample of the
general population). In the years since we
gathered these data, the curve has drifted
up a little bit but it is still very much level.
Indeed, one of the most sober and rational
assessments that I can give you is that our
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patients with ileostomy now can get life in
surance at competitive rates.
I would also like you to consider the
patient with total colonic involvement and
to compare his expected mortality with and
without surgery. The cumulative mortality
on present day conservative management,
combined with major surgery when it be
comes necessary, is much higher than the
cumulative mortality after elective procto
colectomy (Fig. 3). To put this in somewhat
bold and simplified terms, if you have total
involvement of the colon by ulcerative colitis,
and if you accept medical management for
25 years, you have a fifty-fifty chance of
living or dying. But if you have an elective
proctocolectomy, there is a greater than
90% chance that you will be alive after 25
years.
This comparison applies to all patients,
including the elderly. It is true that for
elderly patients, elective major surgery is a
much more serious hurdle and, in fact, 20%
will succumb to causes related to the opera
tion in the following two to three years. But
the medical management of these patients
with present-day methods is even more
hazardous and therefore I don’t think that
we may put off surgery just because the pa
tients may suffer from handicaps (such as
blindness or muscular skeletal disability)
that may make an ileostomy a totally un
realistic alternative; but having considered
such exceptions, I repeat that one should
not put off elective surgery simply because
the patient is over 60 years of age.
If we now look at patients with distal
colitis or ulcerative proctitis (and these form
%
Cumulative
Mortality

50r

L

10

15

20

Time (years) after Operation
Fig. 2.—Cumulative mortality following surgery

for ulcerative colitis. (Reproduced by permission
from G o l ig h e r JC, editor: Ulcerative Colitis,
London, Bailliere Tindall, 1968, p 528.)
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Fig. 3.—Cumulative mortality with conservative

management compared with that from proctoco
lectomy. (Reproduced by permission from W a t t s
JM, d e D o m b a l FT, G o l ig h e r JC: Long-term
prognosis of ulcerative colitis. Br Med J 1: 1447,
1966.)
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a large percentage of the total group), the press them hard enough, that they have
cumulative mortality over 25 years is just some degree of inconvenience from their
about the same with or without elective ileostomy. It is an important factor which
surgery. I do not think therefore that nowa must be taken into account.
days we should systematically advocate sur
So, in trying to formulate a broad man
gery for all patients with distal colitis or agement policy for patients with ulcerative
proctitis, although occasionally such a pa colitis (Fig. 4), perhaps we should bear the
tient will come to operation for a specific following points in mind. For patients with
indication.
rectal disease alone, the mortality of con
So far I have assumed that the only point servative therapy over the years is less than
that matters is the survival of the patient. 2% while the mortality after proctocol
However, I am extremely aware that the ectomy is of the order of 7 %. Furthermore,
quality of life the patient leads after total the patient has the inconvenience of an
proctocolectomy is crucial. In fact, 10% ileostomy. Thus, generally speaking, we
to 20% of our patients will admit, if you would not recommend proctocolectomy for
ulcerative proctitis and we are inclined
towards conservative management. We are
CONSERVATIVE
OPERATIVE
more equivocal about the patient with
distal or left-sided colitis, or procto
sigmoiditis because, in rough terms, the risk
R ectal
to life of conservative management over a
( 20%)
period of over 20 to 25 years is about 10%,
and this is just about the same as the risk of
proctocolectomy. In addition, the surgical
patient has an ileostomy and I think this
perhaps would influence us slightly in
favour of conservative management. But I
think that in patients with total involvement
of the colon and rectum, there is such a risk
D istal
to life on continued present-day medical
(35%)
management, we would be inclined to
favour the much lower risk to life after
proctocolectomy and accept any problems
that the ileostomy brings.
Finally, we are looking at ulcerative
colitis in Leeds yet again and although the
T o ta l
results from our most recent survey, cover
(45%)
ing up to 1974, are not complete, I can tell
you that our current data do not change
very much the overall conclusions I have
just presented to you. This is disappointing
in view of the many recent developments in
conservative management, but it does vali
date perhaps the conclusions I have just
4.—Comparison of the risks of conservative
described.
and surgical management in ulcerative colitis.
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ISCHEMIC BOWEL DISEASE
MUCOSAL INJURY IN LOW FLOW STATES
GUSTAVO BOUNOUS

of the intestinal mucosa as a com
plication of prolonged circulatory insuf
ficiency has been studied extensively since
it was first described by Dupuytren in 1823
in patients who died in shock following ex
tensive burns. The lesion has been reported
under the names: non-occlusive mesen
teric ischemia or infarction, ischemic en
teropathy, mesenteric ischemia without
vascular occlusion, tryptic enteritis, terminal
hemorrhagic necrotizing enteropathy.
The rarity with which antemortem diagnosis
is made at the present time and the post
mortem autolysis of the intestinal mucosa
preclude a reliable estimate of its actual
frequency. It is also possible that often this
condition goes unreported because of the
negative nature of the important feature —
absence of vascular occlusion. Most cases of
ischemic enteropathy have been described
as following congestive heart failure. Oc
casionally, it can develop after severe burns
or as a postoperative complication in critic
ally ill patients. The lesion appears as
patchy, segmental or diffuse areas of dark
red mucosa; its distribution is without rela
tion to the vascular pattern and usually
there is no involvement of the muscular and
serosal layers; the submucosal vessels are
dilated. Histologically, the mucosa is necro
tic, often hemorrhagic. The necrotic process
appears to have its origin in the absorbing
cells near the tip of the villus, then spreads
to the lamina propria and to the other
epithelial cells covering the villus. Crypt
cells are usually preserved. The lesion can
be found almost anywhere in the small and
large bowel although it is most frequently
found in the terminal ileum.
Why is the mucosa of the intestine the
first apparent anatomical site of degenera
tive necrosis during severe circulatory insuf
ficiency? Ischemic enteropathy has been
attributed in the past to a selective reduction
of intestinal mucosal blood flow aimed at pro
tecting more vital organs. Modern techniques

N e c r o s is

of investigation have demonstrated, however,
that this is not the case and that actually a
certain degree of autoregulation protects in
testinal capillary flow during shock. A more
appealing theory is based on the intestinal
countercurrent exchanges of oxygen; the
proximity of inflow and outflow vessels in
the lamina propria allows diffusion of oxy
gen at this level during low flow states
thereby short-circuiting the capillary bed
at the tip of the villus. A second element of
greater intestinal vulnerability to ischemia
is the particular intestinal milieu. During
profound circulatory insufficiency the bio
synthesis of mucin, a rapid-energy-requiring
process, is very soon affected by decreased
cellular respiration. The loss of the mucus
barrier exposes the mucosa to the activity of
pancreatic proteases (Fig. 1) and other po
tentially injurious elements that may be
present in the chyme. In fact, hemor
rhagic enteritis in experimental shock is
minimized either by previous ligation of
pancreatic ducts or pretreatment with an
elemental semihydrolyzed diet. Therefore,
it would appear profitable to pursue the
concept that the qualitative aspects of the
intestinal content play an important role
in the maintenance of mucosal integrity fol
lowing severe circulatory insufficiency.

.

Fig. 1 —Effect of local pre-treatment with a
trypsin and chymotrypsin inhibitor (area between
arrows) on the development of hemorrhagic ne
crosis in the ileum of a dog during severe shock.
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CLINICAL FEATURES OF ISCHEMIC BOWEL DISEASE
HENRY HADDAD
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The clinical features of intestinal ischemia,
regardless of the cause, are similar in most
cases. The diverse clinical settings are more
a reflection of the amount of ischemic
damage than of the cause or location of the
ischemia. Acute mesenteric ischemia can be
suspected on the basis of the history and
physical examination but a firm diagnosis
and determination of its cause usually re
quire detailed radiological investigation in
cluding barium studies, arteriography and
even surgical exploration.

there is a “surgical abdomen” may destroy
the patient’s only chance of survival.
Pain is present in almost all cases of
ischemia. The early colicky and perium
bilical pain soon becomes severe, steady and
poorly localized. Many associated symptoms
have been recorded—anorexia, nausea,
vomiting, diarrhea, con stipation, melena
and hematemesis. But these are seldom
helpful in pinpointing the diagnosis. One of
the most characteristic features is the lack
of significant abdominal signs even when
the pain is unbearable. Severe abdominal
V ascular D isorders of the
distension is frequently found even when
S mall B owel
peristalsis is present. Evidence of gastroin
testinal bleeding can also be found in most
Acute Occlusion of the Superior
patients but it is seldom gross except when
Mesenteric Artery
the colon is involved. With the progression
of ischemia, peritonitis develops. A peculiar
This condition continues to carry a mottled cyanosis of the abdominal wall has
mortality rate of over 90%. The only been reported. When the amount of
hope of decreasing the morbidity and mor ischemic bowel is large, dehydration is
tality lies in elective surgery of chronic in frequent and severe shock eventually
testinal ischemia and in the early diagnosis develops. Laparotomy at this stage usually
and management of the acute episode.
represents a futile gesture.
Diagnosis of acute occlusion of the su
The SMA may be occluded by an em
perior mesenteric artery (SMA) is still com bolus or by thrombosis. Early diagnosis is
monly made at a stage when extensive more likely with embolism because of an
resection of gangrenous bowel is necessary. associated cardiac arrythmia. SMA oc
Tradition dictates that these patients should clusion resulting from thrombosis is more
present with sudden onset of severe abdo difficult to diagnose as less than half of
minal colic, followed by the passage of these patients have a history of heart dis
mucus and blood per rectum and, in a few ease. An epigastric bruit may be present.
hours, signs of peritonitis and shock. We Prodromal symptoms of chronic ischemia
should, however, recall that when the blood are often difficult to evaluate but on occa
supply to the small bowel is interrupted, sion they may be obvious; they antedate the
bowel wall ischemia proceeds outwards acute attack in as many as 50% of the
from mucosa and only with serosal involve patients. One of the major problems in the
ment is there a peritoneal reaction. It is evaluation of these patients is the lack of
during the early period before infarction is correlation between the anatomical defects
complete that the opportunity for corrective shown by arteriography and the clinical
arterial surgery exists.
symptoms.
Acute mesenteric thrombosis may present
quite insidiously, beginning with mild ab
Non-occlusive Mesenteric Ischemia
dominal cramps, and the condition of a pa
tient with severe intestinal damage may re
A most dramatic development over the
main normal for hours and even days. The past 15 to 20 years has been the emergence
clinician’s usual inclination to wait until of non-occlusive mesenteric ischemia as a
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frequent and potentially treatable condition.
A recent computer analysis showed that
it was impossible to differentiate patients
with occlusion of a major vessel from those
with perfusion defects. Non-occlusive mes
enteric infarction usually occurs in elderly
patients with diffuse atherosclerosis. How
ever, other conditions may be responsible,
such as generalized peritonitis, pancreatitis,
septicemia, cerebral disorders and advanced
malignant neoplasms.
Small Vessel Disease
Changes in the smaller and more distal
arteries tend to affect shorter segments of
bowel. Clinically there is abdominal pain
with evidence of intraperitoneal inflamma
tion. Causes of this type of lesion include:
systemic lupus erythematosus, rheumatoid
arthritis, radiotherapy, allergic vasculitis,
sepsis and potassium-induced intestinal
ischemia. Stenosis may develop with result
ing malabsorption or partial small bowel
obstruction. Such malabsorption is non
specific and its ischemic etiology cannot be
established by any of the currently used
absorption studies.

Vol. 17

the most common sites. The rectum is not
always spared and recent reports have
documented the entity of ischemic proctitis.

N

Gangrene of the Colon
Gangrene of the colon usually occurs in
the sixth or seventh decade of life. There is
frequently associated cardiovascular dis
ease. The onset is usually sudden with very
severe generalized abdominal pain, worse
on the left side, nausea and vomiting. These
symptoms are followed shortly by profuse
diarrhea and the stool may contain blood.
On examination there is evidence of intra
peritoneal inflammation and occasionally
intestinal perforation. If the rectum is in
volved, proctosigmoidoscopy reveals hem
orrhagic ulceration or extensive mucosal
edema and friability. An adherent whitish
or greyish membrane may cover the mu
cosa. A precise diagnosis as this stage may
not be possible but it is usually clear that
immediate laparotomy is indicated.
Reversible Ischemic Lesions

In most episodes of colonic ischemia the
clinical, radiological and pathological
changes are completely reversible. The pa
Celiac Axis Syndrome
tient presents with a short history of left
This syndrome is due to stenosis or throm sided or lower abdominal pain which is
bosis of the celiac artery, caused by ex soon followed by bloody diarrhea. Blood
ternal compression or atherosclerosis. Ob loss is usually minimal. A history of previ
struction due to external compression re ous bowel disorders is frequently lacking.
presents an unusual and controversial cause Physical examination usually reveals ten
of bowel ischemia. Most patients are young derness over the involved segment of colon.
women complaining of vague post-prandial Signs of peritoneal irritation persisting for
pain. An epigastric bruit can usually be more than a few hours should be considered
heard. Not all patients are relieved by re as evidence of irreparable tissue damage.
moval or division of the compressing Fever and leukocytosis are helpful in asses
sing the progress of these lesions.
structures.
Sigmoidoscopy is of value when the
rectosigmoid colon is involved.
V ascular D isorders of the C olon
The early development of pseudotumours,
Ischemic disease of the colon, regardless resulting from submucosal hemorrhages, is
of cause, produces the same spectrum of pathognomonic of ischemia. Within several
pathological, clinical and radiological mani days large ulcerations replace these masses
festations. The outcome depends on the and the appearance is no longer specific.
Early and repeated barium enemas are
severity of the ischemia. The majority of
episodes of colonic ischemia produce essential to the diagnosis of colonic isch
transient and reversible changes. Any part emia. The pathognomonic thumbprints (Fig.
of the colon may be involved but the splenic 1) disappearing on subsequent studies are
flexure, descending and sigmoid colon are the major sign. These changes are thought
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to be due to submucosal hemorrhages which
are subsequently reabsorbed or evacuated.
A barium enema one week after the onset
of the process may show either a return to
normal or a pattern of segmental colitis.
Once the latter pattern has developed, the
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ischemic nature of the disease may be
missed. It is important to realize that this
condition is marked by a constantly changing
picture.
Fibrotic Ischemic Stricture
With a more severe degree of infarction
a stricture (Fig. 2) will develop after
several weeks. Continued bleeding suggests
stricture formation. The symptoms may be
those of incomplete large bowel obstruction.
The typical site of the stricture is the splenic
flexure but it may occur in any part of the
large bowel, including the rectum.
Chronic Ischemic Proctitis

Fig. 1.—Barium enema showing thumbprinting
of the descending colon.

The entity of chronic progressive ischemic
proctitis has now been documented. The
symptoms are non-specific. Proctoscopy
shows discrete ulcerations. Deep rectal bio
psy may suggest an ischemic process.
It may be difficult to differentiate this
entity from other forms of inflammatory
bowel disease. This is especially true in the
older age group, in whom there is a second
ary rise in the prevalence of the other forms
of inflammatory bowel disease. The fin ding
of vascular pathology at arteriography can
not be taken as definitive proof of the isch
emic nature of the bowel lesion. What is
important in the final analysis is the blood
that actually reaches the mucosa and there
is, as yet, no clinical test to measure this.
Mesenteric Venous Occlusion

Fig. 2.—Ischemic stricture of the descending
colon.

The incidence of venous occlusion in re
ported series of bowel ischemia is less than
10%. Acute occlusion may occur with hypercoagulable states, carcinoma, portal hy
pertension, sepsis, extrinsic compression, di
rect injury and the use of contraceptive
pills. It may develop spontaneously without
demonstrable cause. Clinically the disease
may present as a fulminating abdominal
catastrophe. In other cases, especially those
without demonstrable cause, symptoms of
abdominal discomfort, anorexia and change
in bowel habit develop over a period of one
or two weeks. Physical findings are non
specific. Superior mesenteric arteriography
shows a prolonged arterial phase and failure
to opacify the venous system.
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ANGIOGRAPHY IN ISCHEMIC BOWEL DISEASE
D. DILENGE
A ngiography plays a useful role in the

diagnosis of intestinal ischemia. It is of value
both in the occlusive form, where it permits
an objective evaluation of the nature and
degree of arterial obstruction, and in the
non-occlusive form. In the latter, by exclud
ing occlusive disease arteriography may al
low us to postulate other conditions which
are associated with a reduction in arterial

flow or with an increase in the distal vas
cular resistance (capillary or venous).
Stenosis or obliteration of one or more
of the mesenteric arteries is usually arterio
sclerotic in origin and usually involves the
origin of any of the three main mesenteric
arteries. Signs of coexisting aortic and
generalized arteriosclerosis are frequently
present. Less frequently, the calibre of the
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Fig. la
Fig. 1.—Completely asymptomatic thrombosis of the celiac and superior mesenteric arteries,
(a) Contrast material injected into the aorta shows a grossly dilated inferior mesenteric artery
(large arrow). This provides adequate arterial supply to the territories of the thrombosed vessels by
shunting blood via the marginal artery of Drummond (small arrows) and anastomotic vessels. Note
on (b) the retrograde filling of the celiac artery (arrow) and its branches.
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arteries may be reduced by other causes.
Among these are compression by neighbour
ing aneurysms of the aorta, fibrous dysplasia,
emboli and traumatic lesions.
However, it is well known that stenosis
or even complete obliteration of one or
more of the three mesenteric arteries may
be asymptomatic. The development of symp
toms, among other things, depends on the
efficiency of the collateral circulation. Such
an event is well illustrated in Fig. 1.
The development of transpancreatic anas
tomotic pathways produces a typical mor
phology (Fig. 2).
There are numerous examples in the lit
erature of severe arterial lesions associated
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with a complete absence of ischemic mani
festations. Chienne, in 1969, during the
course of an autopsy, noted a complete
thrombosis of the celiac axis and of the supe
rior and inferior mesenteric arteries in a pa
tient who probably died from unrelated
causes.
To illustrate some of the angiographic
ieatures of the occlusive form of intestinal
ischemia, I will present five cases studied
during the past five years.
Case R eports
Case 1.— A 58-year-old man presented a
clinical picture suggestive of abdominal an
gina. Angiography of the abdominal aorta

440

TH E CANADIAN JOURNAL OF SURGERY

Vol. 17

'

,1
S

*
V

1
V

Fig. 2.—Stenosis of the celiac artery. Note the
anastomotic network between the superior mesen
teric artery (right-hand arrow) and the right he
patic artery (left-hand arrow) in the region of the
pancreas. Anastomoses are typically tortuous.

Fig. 3.—Arteriography in a patient with abdominal
angina. There is a severe narrowing of the origins
of the celiac (top arrow) and superior mesenteric
(middle arrow) arteries well seen on the lateral
view (a). The mesenteric artery (bottom arrow)
is poorly filled (a).
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Fig. 3b
Fig. 3.—(b) On the anteroposterior view there is an obvious reduction in the number of pa
tent branches coming from the celiac and superior mesenteric arteries.
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Fig. 4b
Fig. 4.—Selective arteriography in a patient with

abdominal angina, (a) The injection of the superior
mesenteric artery shows changes in the calibre of
several branches (arrows) which are known as
“stationary arterial waves” and are typical of
fibrous dysplasia, (b) The injection of the inferior
mesenteric artery in the same patient reveals a
different variety of vascular anomaly in the left
colic (simple arrow) and sigmoid arteries (weight
ed arrows). These aneurysmal dilatations (white
arrows) in a “string of beads” pattern are most
marked distally.

Fig. 5.—Ischemic colitis. Selective angiography
of the inferior mesenteric artery demonstrates a
narrowing at the origin of the sigmoid and superior
hemorrhoidal arteries (arrow). This severe stenosis
causes a prolongation of the circulation time in
these two vessels as contrast material remains in
the late phase of the serial films.
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(Fig. 3) prior to surgery revealed not only
numerous irregularities at the level of the aorta
but also an important reduction in the mesen
teric vascular supply. Pathological examination
confirmed the presence of an ischemic bowel
lesion.
Case 2.—A 32-year-old woman appeared to
have mesenteric angina. Angiography revealed
typical signs of fibrous dysplasia (Fig. 4). The
associated “string of beads” aneurysmal dilata
tions have not, to our knowledge, been reported
previously.

Fig. 6.—Ischemic proctitis. The stenosis seen at
the origin of the inferior mesenteric artery (arrow)
appears to be in this case the only obstructive le
sion responsible for the rectal lesions.

Case 3 .—The clinical picture in a 67-yearold man was dominated by abdominal pain,
weight loss and rectal bleeding. Ischemic colitis
was suspected. Selective angiography (Fig. 5)
revealed a severe stenosis of two branches of
the inferior mesenteric artery. A striking hemo
dynamic phenomenon was observed—the
vascular territory of these two arterial branches
remained opacified long after the injection.
This has been interpreted as a sign of reduced
blood flow.
Case 4.—A 56-year-old woman with proc
titis was found to have a stenosis of the inferior

Fig. 7.—Ischemic proctitis. Ischemia was precipitated by carbon monoxide poisoining in this patient
with stenosis of the origins of the celiac, superior mesenteric (left-hand arrow) and inferior mesenteric
(right hand-arrow) arteries. Treatment of the poisoning was followed by rapid recovery.
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mesenteric artery (Fig. 6). The reversibility of
symptoms and the healing of the rectal lesions
after vascular surgery supported our diagnosis.
Case 5.—This case is of particular in
terest. A previously asymptomatic 43-year-old
man developed ischemic proctitis following
carbon monoxide poisoning. Angiography de
monstrated a significant stenosis at the origin
of the superior mesenteric artery (Fig. 7) and
an additional stenosis at the origin of the in
ferior mesenteric artery. As in the preceding
case, the signs of reduced blood flow could

443

be demonstrated in the territory of the inferior
mesenteric artery. The proctitis resolved com
pletely. This case illustrates how, in the pre
sence of a precarious but usually adequate
blood flow, a concurrent insult may precipitate
ischemia of the bowel.
Finally, I would like to show the case of
a patient presenting with discrete rectal
ulcers (Fig. 8). Certain authors consider that
such lesions may be ischemic in nature;
angiography in this patient showed opaci
fication of the ulcer sites.

Fig. 8.—Ulcers of the rectum. Selective injection of the inferior mesenteric artery supplemented
by the subtraction technique reveals two areas of increased density (arrows) corresponding to two ul
cerations confirmed at operation.
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SURGICAL TREATMENT OF ISCHEMIC BOWEL DISEASE
D. C. McILRATH

I would like to summarize some of the
things the previous speakers have said in
dealing with the subject of ischemic bowel
disease and touch upon some practical as
pects I have found important in manage
ment.

Table I gives a very simple classification
of the causes of intestinal ischemia. They
are divided into arterial and venous groups
and the arterial group is further subdivided
into occlusive and non-occlusive lesions.
Certainly the non-occlusive form has been
well reviewed by the other speakers. With
regard to the lesions that do cause vas
cular obstruction sufficient to produce a
clinical problem, we are talking, essentially,
about four things. The first is embolization
which, in our experience, usually results
from some cardiac problem, either atrial
fibrillation or a mural thrombus develop
ing after myocardial infarction. One should
be alert to the diagnosis of embolism and
look for a possible source. In fact, it occurs
not only in patients with known heart dis
ease but also when there is no clinically
recognizable heart problem.
Thrombosis usually complicates chronic
atherosclerosis. Polyarteritis and other in
flammatory arterial lesions of the bowel
must be kept in mind and, fortunately, often
affect a small segment of the intestinal tract
which is easily resected. The hazard in this
particular situation is that these patients
are often very ill as a result of their sys
temic disease.
Compression of the arterial tree has al
ready been mentioned and is a condition
recognized by some. It is known as the
arcuate ligament syndrome, celiac compres
sion syndrome, Nicholson’s syndrome, all
terms referring to compression of the celiac
trunk or superior mesenteric artery. We
have, unfortunately, also seen several pa
tients in full body casts in whom a compres
sion of the arterial tree has developed
sufficient to produce gangrene of the entire
small bowel and, in some instances, of the
stomach and the proximal colon. As a re
sult, when any patient who is in a full body

cast develops distension of the abdomen or
some other type of gastrointestinal distress,
one should keep in mind the possibility of
compression of. the visceral arterial supply.
In Table I the condition is broken down
in perhaps a simpler way, according to the
extent of the ischemic lesion. Unfortunately,
extensive acute lesions usually involve most
of the small intestine and resection does not
solve the problem because the remaining
bowel is too short to support life. In the
chronic form, diffuse atherosclerotic disease
affects at least two of the major vessels sup
plying the gut. In our experience this has
been a tragic situation that is seldom helped
by surgical intervention. These patients are
thin and emaciated and develop abdominal
pain with any challenge such as a meal
which increases the need for perfusion of
the intestinal tract. If one does arteriographic studies the disease is often found to be
so diffuse that a bypass or revascularizing
procedure is not satisfactory.
Such studies should not be omitted, how
ever, because there will be the occasional
patient for whom it is possible to provide
significant help. In segmental disease, in
farction of one or two feet of bowel may
occur so that resection is possible without
disturbing the greater part of the intestine.
Clinically, infarction of the small intestine
will typically manifest itself by the abrupt
onset of pain, vomiting and diarrhea. The
blood pressure tends to fall, the pulse accelTABLE

I.— I ntestinal

I schemia

Causes:
1. Arterial
Occlusive
Embolization
Thrombosis
Polyarteritis
Compression
Non-occlusive (malperfusion)
2. Venous
Occlusive
Types:
1. Extensive
Acute (infarction)
Chronic (abdominal angina)
2. Segmental
Ischemic colitis
Segmental infarction of small bowel
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erates, and the abdomen progressively be
comes distended and tender.
There are three different approaches to
the surgical treatment of acute small bowel
ischemia. The first is resection of the intes
tine, and usually it is the only thing that
can be done. Klass, in 1951, described
embolectomy. We have not encountered too
many patients in whom this was possible
and where the bowel remained viable.
Marston has reported going through the
ileocolic artery, using a catheter to extract
the thrombus from the superior mesenteric
artery, and then anastomosing the ileocolic
artery to the iliac artery.
As far as abdominal angina is concerned,
it is a more chronic form of disease, with
pain after meals, loss of weight, diarrhea,
and perhaps an audible abdominal bruit.
In these cases, a very careful interpretation
of an arteriogram may suggest what might
be accomplished by surgery. The celiac ar
tery compression syndrome tends to occur
in young women who often have had sev
eral operations in an attempt to cure ab
dominal pain. This pain is often vague and
does not fit any of the usual pain patterns.
There may or may not be a bruit. The cor
rection of this problem is, of course, to
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release the arcuate ligament. We have not
treated surgically enough patients with this
condition to determine for ourselves wheth
er the concept is valid, but there are cer
tainly enthusiasts with large series.
Boley, in his description of ischemic co
litis in 1963, pointed out its various clinical
manifestations. Pain of acute onset may
develop, with or without nausea and vomit
ing, and, often, rectal bleeding as well as
tenderness and abdominal distension. Proc
toscopic examination may be helpful. The
radiological findings have been mentioned
earlier. Arteriography, unfortunately, is not
often helpful because in a large percentage
of healthy individuals the inferior mesen
teric artery is not visualized. In regard to
surgical treatment, the acute case may de
velop peritonitis and one must operate to
resect the affected bowel. In some patients
the acute lesion is less severe but leads to
a stricture which may produce obstruction
or pose a problem of differential diagnosis
from a malignant lesion. When surgery is
necessary for such a lesion, satisfactory re
sults can usually be obtained by segmental
resection of the affected bowel and, if the
bowel has been prepared beforehand, it can
be accomplished as a one-stage procedure.

GENERAL DISCUSSION
D r. M cM anus : T o start our discussion
period, I would like to ask Mr. de Dombal
to clarify for me his statistics on long-term
survival after proctocolectomy for ulcerative
colitis. It seems to me that on the graph
he presented, the mortality curve was almost
parallel to the abscissa, which would repre
sent practically no mortality on long-term
follow-up. This certainly has not been our
own experience in Edinburgh.
M r. de D ombal : I think we are talking
at cross purposes; what I have been dis
cussing is long-term disease-related mortal
ity. I am sorry if I have not made this
absolutely clear. We are talking about two
things: one is a long-term disease-related
mortality after proctocolectomy, and al
though this is not parallel to the abscissa,

it is not far from it. As I have mentioned
before, some hard-headed insurance men in
Leeds will give our patients life insurance
at competitive rates. But, in addition to
what the figure presents, there is an appre
ciable unrelated mortality after proctoco
lectomy and this is almost within 1% of
the mortality observed in a sample of the
population matched for age and sex. So,
there are two components to mortality ob
served after total proctocolectomy. If you
want a further semi-anecdotal piece of evi
dence to support the correctness of our
statistics, some of our patients with ileo
stomies have been claiming they deserve
better life insurance rates than the rest of
the population because, as they say, they
cannot develop cancer of the colon.
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D r . D evroede : I would like to support
Mr. de Dombal because three years ago we
published the Mayo Clinic’s experience with
ulcerative colitis in children. We compared
the survival of the children undergoing
proctocolectomy with that of the other childen who did not have this operation. We
did not exclude unrelated death from our
statistical analysis. There was a significantly
higher survival in the group that had proc
tocolectomy. Also, there was no statistical
difference between the long-term survival
of the group with proctocolectomy and a
matched normal control population. Like
others, we noted an 18% drop in survival
during the first two years after operation
but this was a retrospective study and in
cluded children who had surgery for a vari
ety of reasons and those undergoing emer
gency operations for major life-threatening
complications. In spite of this initial, rather
high, mortality they had a better chance
of long-term survival than the others who
did not have definitive surgery.
M em ber of the A u d ie n c e : Earlier, one
of the speakers made reference to the fact
that ulcerative colitis starts in the rectosig
moid colon and then spreads proximally.
This has been described in a number of
books on the subject. Personally, I have
never seen this progression of ulcerative
colitis and, in my experience, the disease
is either localized and remains localized in
the rectosigmoid area or it is already gen
eralized at the time the patient is first seen.
I would like to hear about your experience
on this matter.
D r . L ennard -Jo n e s : We have followed up
a group of patients, just as you have de
scribed, with ulcerative proctitis. This was
in the 1960s, and we made the diagnosis
when we could see the upper limit of the
disease on sigmoidoscopy. Over 10% of
them went on to develop more extensive
or total colitis. The Leeds experience, if I
may speak for Mr. de Dombal, also shows
that a proportion of the patients develop
more extensive colitis, but perhaps he would
like to elaborate on this subject himself.
M r . de D o m b a l : While I agree with Dr.
Lennard-Jones that ulcerative colitis does
tend to progress, the question raises a num
ber of interesting problems. I wonder wheth
er, in fact, there is a more extensive disease
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to begin with but the radiologists are just
not able to document this. If this were the
case, then with improvements in diagnostic
methods we would expect in our more re
cent results to have a smaller proportion
of patients with initial proctitis developing
total colitis and I think we have some evi
dence that this is true.
It may well be, therefore, that this is one
of the reasons for the conflicting views in
the literature but, even so, looking at our
latest data, I am reasonably certain that
10% to 15% is a fair figure for those with
originally distal disease who are going to
develop more extensive or total involve
ment of the colon over the next 20 years.
Our problem is that to test this hypothesis
would require a 20-year follow-up period.
D r . D e v r o e d e : Like the member of the
audience, I too have never seen a case of
ulcerative proctitis progress to total colitis.
I feel that the limitations of our diagnostic
methods have given misleading information.
In the past year I have seen five patients
with a disease that was diagnosed as distal
colitis on x-ray which actually turned out
to be total colitis on colonoscopy. The first
of these had a barium enema in 1968, and
a radiological diagnosis of distal colitis was
made. Later, the barium enema was re
peated in our institution and the radiologists
again reported distal colitis. At colonoscopy
the patient had total colitis going all the
way around to the cecum as proved by
biopsy, and in one of the rectal biopsy spe
cimens we found a carcinoma in situ. So
I feel that the question of progression is
far from settled. It is possible that there
is a progression from proctitis to procto
colitis but it is also equally true that very
often we do not appreciate the true extent
of the disease initially.
D r . L e n n a r d -J o n e s : There is one useful
diagnostic point I would like to mention.
Patients with proctitis usually pass solid
stools, and if you have a patient who has
so-called proctitis but who passes frequent
liquid stools, it is almost certain that he has
extensive colitis. We have had patients with
total colitis and completely normal x-rays
so perhaps this point is one of the useful
distinguishing clinical features. Reverting to
some of the presentations on ulcerative co
litis from Mr. de Dombal and Dr. Devroede,
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both of whom I respect greatly, it must be
remembered that they do represent a par
ticular attitude to the management of total
colitis. Now, I am going to be thoroughly
provocative here but I do have the neces
sary data to back my words. The problem
in reaching conclusions about the manage
ment of total colitis is that many of the
series published have dealt with the early
days before our current concepts of man
agement were developed. Just to give you
an example, Dr. Devroede’s study of chil
dren began in 1919, and Mr. de Dombal
presented data from the early 1960s. Now,
I am in complete agreement with Dr. McIlrath that surgery plays a vital role in the
treatment of colitis and about 20% of our
own patients eventually require surgery. The
difficulty for the person treating colitis is
to get a balanced view on the subject. At
our own institution we have been prospec
tively following up patients with extensive
colitis since 1966. Our policy is that they
are treated surgically if they do not respond
rapidly to medical treatment during their
first admission, if they have recurrent severe
attacks of colitis, if there is a long history
of disease, or if, in our opinion, there is
an increased risk of malignancy. All chil
dren who fail to grow are also treated sur
gically. With the indications mentioned, the
likelihood of surgical treatment for extensive
ulcerative colitis at our hospital, computed
actuarily, is about 20% in five years. We
must not regard all patients with total colitis
as the same, because there are individual
differences. In the patients in our series
who had no surgical treatment the excess
mortality due to colitis over a five-year
period was 0.003/patient/year.* This is
much less than the mortality that Mr. de
Dombal has shown us. I think it is fair to
say that quite a high proportion of patients
with total colitis do need surgical treatment
— and I would admit to this without any
qualification whatsoever—but there is also
a proportion of patients who can continue
with medical treatment, remain well and
have a low mortality. The other recent series
on the management of colitis comes from
Copenhagen and was published in the Scan*Lennard-Jones JE, M isiewicz JJ, P arrish JA,
et al: Prospective study of outpatients with ex
tensive colitis. Lancet 1: 1065, 1974.
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dinavian Journal of Gastroenterology this
year. This is a study by Dr. Riis and his
colleagues who have very similar indications
for total colectomy.* Their mortality from
colitis is extremely low. They also have
about a 20% operation rate at five years
and, interestingly but not unexpectedly,
their mortality rate tends to follow surgical
treatment because surgery is reserved for
their more seriously ill patients. I regard
this survey from Copenhagen as superb. It
is a group taken from one geographical
area, it is not selected and it is beautifully
analyzed by actuarial methods. I do think
it is an absolute classic on this subject and
I commend it to you.
D r . D evroede : I am afraid I do not have
the experience of Dr. Lennard-Jones and
what I am going to say represents mainly
the Mayo Clinic experience with ulcerative
colitis in children. Needless to say, several
questions may be raised about the validity
of our data. First, the treatment in 1919
was not the same as in 1974; second, the
availability of steroids may have drastically
changed the prognosis; and, third, the Mayo
Clinic population is a highly selected one
and represents a small segment of the total
population with ulcerative colitis. To an
swer some of the questions raised, we did
look at survival before and after 1953, the
year when steroids became available for the
treatment of ulcerative colitis, and we found
the survival rates before and after that date
to be identical. So it seems that we have
made no progress in this respect. As
Weedon and Taylor have shown, we have
made progress in Crohn’s disease but cer
tainly not in ulcerative colitis. To test the
validity of the argument that referred pa
tients do not form a representative group,
we analyzed the life history of the children
who developed cancer and classified their
ulcerative colitis as mild, moderate or severe
from onset to cancer detection. Of these
patients 75% had mild or moderate ulcer
ative colitis and yet they developed cancer.
So it was not because the Mayo Clinic chil
dren were more acutely ill with ulcerative
colitis that they showed a high incidence
*Bonnf.vie O, Binder V, A nthonisen P, et at:
Prognosis of ulcerative colitis. Scand J Gastroen
terol 9: 81, 1974.
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of cancer on medical management. There
fore we feel that having mild colitis is no
insurance against malignant change. Finally,
Dr. Taylor, consultant in statistics at the
Mayo Clinic, modified the actuarial method
used to eliminate the problem of losing pa
tients during the follow-up period. His
method also took into account the year
after the onset of the disease when the pa
tient was first seen at the Clinic and entered
in the study. Mr. de Dombal, you have
stated earlier that the burden was upon the
physician to prevent cancer in patients with
total colitis and I think this is a very im
portant point. We have had some hopes
with the carcinoembryonic antigen but
Janowitz of New York has just published
his results, indicating that CEA determina
tion is not a useful screening procedure.
D r . L ennard -J o n es : Please, I do not want
anybody to misunderstand me and think
that I do not believe in surgery for ulcer
ative colitis, because I do! And I do be
lieve that the risk of cancer in patients with
extensive or total ulcerative colitis, with a
history of over 10 years, is very great. I
think that these patients must be followed
up very carefully and, if this is not possible,
surgical treatment is the right thing for
them. We feel that in our particular hos
pital, with the facilities at our disposal, we
can keep track of our patients and so far
our results, in my opinion, have been rea
sonably acceptable. Like Dr. Janowitz, we
have also studied the CEA antigen and
have found it to be of no use in detecting
early cancer. I know there is a consider
able controversy on the question of dys
plasia in rectal biopsies. We do find it, in
our own experience, to be useful in detect
ing patients at risk from cancer. My prob
lem as a physician is to try to define the
risk for the individual patient rather than
the group as a whole and this is the area
on which we are concentrating our research
at the moment.
M r . de D o m b a l : First of all, one must
agree that our study was not entirely repre
sentative and presented a predominantly
surgical point of view. I think this is an
important comment and I am glad for the
opportunity to discuss it. However, as far
as medical management is concerned, the
results that I have presented were largely,
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or almost exclusively, obtained during a
period when we had an extremely compe
tent gastroenterologist working in our unit
and I really think that the patients received
the highest form of medical management
that was available at the time. And yet,
even he, using conventional methods of
medical management, could not achieve bet
ter results than the results I have presented
to you. Second, the only other thing that
has changed during the past 10 years, as
far as our medical management of ulcer
ative colitis is concerned, is that we have
tried treating our patients with immuno
suppressive agents and our results have not
been very impressive. Since 1953, when the
results of our survey became available, we
have adopted a much more agressive policy
towards patients with total colonic involve
ment and the overall mortality in our series
for these patients has fallen from around
2.7% to around 1%. Finally, in our orig
inal group of patients with total colitis in
whom we have been adopting a very ag
gressive surgical approach, we have now
almost ceased to see severe attacks and
carcinoma over the period of the last 10
years. The severe attacks that we see now
in our own unit are in patients with total
involvement of the colon referred from else
where who have been managed conserva
tively.
D r . K o n o k : Up until now we have been
discussing the treatment of patients in whom
a definitive diagnosis of ulcerative colitis
has been made. Recently we have had cases
where clinically, radiologically and pathol
ogically the disease resembled ulcerative
colitis, yet the evolution of the disease and
the histological findings in rectal biopsies
were not compatible with the diagnosis.
With your permission I would like to pre
sent an actual case history to serve as a
basis for discussion. A 56-year-old woman
was transferred to our care from another
hospital where she had been investigated
and treated for rheumatic pains in her
shoulder. She gave a history of several
years of frequent, loose, non-bloody, green
ish bowel movements. During her initial
hospitalization, she developed crampy ab
dominal pains and a barium enema done
at the time revealed fairly extensive ulcera
tion of the left and transverse colon. Initi-
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ally she was treated conservatively but when
she developed a distended, diffusely tender
abdomen and her general condition deter
iorated, she was transferred to our hospital
for treatment. On admission she had clinical
signs of impending shock, septicemia, an
acute surgical abdomen, free air under both
diaphragms and a distended transverse
colon. Preoperative sigmoidoscopy showed
an essentially normal rectum with a few
punched-out ulcerations and normal inter
vening mucosa. Our diagnosis was fulmi
nating ulcerative colitis and a total colec
tomy with ileostomy was performed. Now,
after a rather stormy postoperative period,
she is doing well and repeated sigmoid
oscopies have shown a normal rectum. I
will ask Dr. Sanchez-Casis to report on the
pathology.
D r. Sanchez-Casis: Inside the specimen
we found longitudinal as well as transverse
ulcerations; in the ascending colon the mu
cosa was almost completely absent; the
transverse and descending colon were less
severely affected. There were several per
forations and the wall of the colon was not
thickened as one usually sees in Crohn’s
disease. On microscopic examination, in the
non-ulcerated colon there were degenerated
crypts with necrotic cells and polymorpho
nuclear leukocytes. Sections from the areas
of ulceration showed that the surrounding
mucosa also participated in the inflamma
tory process which, again, is more charac
teristic of ulcerative colitis than of Crohn’s
disease. There was also quite marked edema
of the submucosa but no evidence of granu
lomas. Many sections were taken and scru
tinized for other entities such as vasculitis
or ischemic colitis, but from the pathological
appearances we favoured the diagnosis of
ulcerative colitis. The postoperative rectal
biopsies showed an almost completely nor
mal mucosa with very minimal inflammatory
changes.
D r. Konok: I would like to ask the panel
to discuss the diagnosis and the advisability
of doing an ileorectal anastomosis.
D r . W eakley: I am very glad that there

is no secret answer that is being withheld
from us. From the data presented I am
convinced that this is a case of Crohn’s dis
ease. You have just heard the many features
with which a nearly typical case of colonic
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Crohn’s disease can present. I would like
to state the evidence that this is Crohn’s
disease. There is segmentation, as shown by
the fact that some areas of the mucosa are
normal and others abnormal; there are dif
ferent degrees of inflammation; there are
areas of relatively normal mucosa adjacent
to mucosal ulcerations, both microscopically
and in the gross specimen; there is a dif
ference in appearance of the ascending,
transverse, and descending colon in the
gross specimen; and the rectum is spared
from advanced disease but has relatively
minimal patchy ulceration and inflamma
tion. All of these findings support the diag
nosis of Crohn’s disease. What makes it
unusual to many observers is that there is
toxic dilatation. Yet we have shown for
many years that toxic dilatation of the colon
can occur in Crohn’s disease. More recently
other groups have agreed that the relatively
short-term, devastating type of Crohn’s dis
ease may manifest itself by toxic dilatation
of the colon. The colon in this type of case
does not have time to acquire the degree of
transmural involvement that we are used to
seeing in the more chronic type of disease.
Therefore my diagnosis is fulminating
granulomatous colitis with toxic dilatation.
With regard to the question of an eventu
al ileorectal anastomosis, it would be my
recommendation that when the patient’s
health is restored and provided the rectum
is spared by the disease, an ileoproctostomy
could be done. It has been our experience
that in the patient who has enjoyed a
year of good health after colectomy and
ileostomy for inflammatory colonic disease
and who has a rectum normal enough to be
expected to perform its function adequately,
takedown of the ileostomy and re-establish
ment of intestinal continuity to the rectum
will result in long-term success in about
two-thirds of such patients.
Before leaving the subject of management
of the patient with toxic dilatation of the
colon, I would like to mention our “less
than colectomy” operation, or simultaneous
decompression and exclusion of the colon.
It consists of construction of a loop ileo
stomy combined with a decompressive colo
stomy. We have observed that the high
mortality of colectomy in toxic dilatation
of the colon occurs when there is transmural
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involvement which has caused perforation facilities available to us, we are able to fol
and air under the diaphragm, or when at the low up such patients very closely with biop
time of operation the surgeon can observe sies, x-rays and, now, colonoscopy. In due
sealed-off perforations. In these cases the course we will let you know about our re
operation of colectomy and ileostomy has sults.
been associated with mortality figures of M r. de D ombal : I would also like to speak
30% to 50% , so we felt there was a need briefly about long-term disease. It seems to
for something less than total colectomy. me that this is something that caused some
Simultaneous decompression and diversion confusion in our earlier discussion. I do not
allow the patient to get over the crisis and, think that Dr. Lennard-Jones and I disagree
at a later time, an abdominal colectomy and about this at all. We both agree that pro
ileostomy (or a proctocolectomy and ileo phylactic proctocolectomy is not necessary
stomy if there is involvement of the rectum) in patients with proctitis alone; also that
can be carried out electively after elimination there is a tenuous argument in favour of this
of the toxic products in the lumen of the operation in distal colitis, in view of our
colon. When we reviewed about 1,000 con present knowledge of the incidence of can
secutive patients treated in our institution cer and of long-term survival under medical
for ulcerative colitis, there were about 60 management. Meanwhile, there is a definite
patients with toxic dilatation of the colon. indication for surgery in patients with total
These were severely ill patients with dilata colonic involvement. I say this because, in
tion of the transverse colon to 10 to 14 cm. addition to cancer risk, half to three-quarters
In approximately one-third of the 60 pa of the patients with total colitis will require
tients we employed a “less than colectomy” surgery anyway, usually during a severe at
type of procedure, because we could observe tack when they are quite ill. Of course if
sealed-off perforations at the time of laparo Dr. Lennard-Jones can show (in a long
tomy, and we felt that manipulation of the term objective study of the type he is cur
bowel would lead to gross peritoneal soil- rently doing) that our aggressive approach
age and sepsis with a prohibitively high is unnecessary, or could be avoided in cer
mortality. Since then, we have extended the tain patients with long-term total colitis,
indication for exclusion and decompression then we would be delighted to adopt what
to the toxic patient who is debilitated but would be a happier, more selective approach.
does not have colonic dilatation. It is this Until that time, with a little reluctance, we
metabolically depleted, ill patient who can would recommend a proctocolectomy and
withstand the colectomy better when his ileostomy for a patient with total colitis of
metabolism has been returned to a more 10 to 15 years’ duration.
anabolic state. We still believe that the treat D r . L ennard-Jones : I think that Mr. de
ment for the unresponsive patient with Dombal is absolutely right. At the moment,
either type of ulcerative colitis is total colec colitis is being divided, basically, into lowtomy and ileostomy. But diversion by ileo risk, medium-risk and high-risk groups. It
stomy and decompression by “blow-hole” can be divided this way both for the acute
colostomy can eliminate the devastating attack and for the long-term risk of cancer.
mortality encountered when definitive sur Now, people with total colitis are the highgery is performed in a period of grave crisis risk group for the acute attack and they are
also in the high-risk group for cancer. As a
or severe depletion.
M ember of the A udience : Is there an generalization the world over, it is better to
absolute indication for proctocolectomy in treat the high-risk group with proctocolec
a patient with total colitis of 10 to 15 years’ tomy. What we are trying to do is to take
the whole problem one step further; what
duration?
D r . L ennard -Jones : I agree with most we would like to do is to pinpoint the in
speakers that patients who have had total dividual patients who are at high risk from
ulcerative colitis for a period of 10 to 15 the acute attack and the individual patients
years should usually have a colectomy. It who are at high risk from cancer. If we can
so happens that in our centre we do not al do this, then one has taken the matter to its
ways do this because we feel that, with the logical conclusion. This is the key question
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and this is what we are trying to do with
our clinical investigation. We may be right,
or we may be wrong, and I hope that in due
course we will be able to give you some
information on this matter, but at the present
time I am not recommending this approach
for everybody.
M ember of the A udience : What rela
tionship has pregnancy to ulcerative colitis
and Crohn’s disease?
M r. de D ombal : This is really a tough
question. Let us take four aspects in se
quence. First of all, does pregnancy in ul
cerative colitis harm the child? We have
looked very carefully at the rate of con
genital abnormalities and stillbirths in ul
cerative colitis and we have no evidence
from our series that a child of a mother with
ulcerative colitis is more likely to be born
deformed or stillborn than one in the gen
eral population. The second question is
whether the mother is more likely to be
harmed by having ulcerative colitis. The
answer is “No” while she is pregnant, but
there is an increased risk in the immediate
postpartum period, when she is about three
times as likely to have an acute attack as
she would if she had not been pregnant. I,
myself, wonder if this is related to the di
minished plasma cortisol levels which are
present at this time, and I also wonder if
there is not an indication for prophylactic
steroids. Perhaps Dr. Lennard-Jones would
like to comment on this later. Turning now
to Crohn’s disease, women with this condi
tion tend to be subfertile. But there is also
another worrying feature, namely that all
reported series include a rather small group
of women whose babies have been stillborn
around the thirty-sixth week of pregnancy.
I feel that it is prudent to hospitalize women
with Crohn’s disease for about the last
month of pregnancy and watch them very
closely. There may also be an indication
for inducing labour early in these women.
Finally, pregnancy has a variable effect on
Crohn’s disease. Some women get worse
during their pregnancy, and others get bet
ter. In summary, I would think there is no
overall indication for prophylactic steriliza
tion of women affected by either disease.
D r. L ennard-Jones : We have not studied
this question directly but we, too, see quite
a number of women with colitis associated
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with pregnancy. On medical grounds I see
no contraindication to pregnancy in these
patients unless they are ill at the time with
their disease. The relapse rate of ulcerative
colitis in pregnancy is the same as the gen
eral relapse rate and when pregnant patients
do relapse we treat them in the same way
as if they were not pregnant. They should
be watched very carefully in the postpartum
period although I, personally, do not give
them steroids prophylactically at this stage.
M ember of the A udience : What is the
medical management of toxic megacolon?
D r. Mc I lrath : One should avoid giving a
barium enema, or any medication which
might enhance the problem. Either measure
not only can precipitate an acute attack but
can also increase its magnitude once it has
begun. Intestinal suction by means of a
nasogastric tube, or a longer tube, is help
ful but the major effort should be directed
toward the prompt and accurate replacement
of fluid and electrolyte losses and restoration
of circulating blood volume as soon as pos
sible so that when surgery becomes neces
sary the operative risk will be reduced.
D r. L ennard-Jo n es : I think it is important
that we define toxic megacolon. The upper
limit of the normal diameter of the trans
verse colon on a plain radiograph of the
abdomen has been defined as 5.5 cm. But
when one makes the diagnosis of toxic
megacolon it is important that, in addition
to the dilatation, mucosal irregularities
should be evident. Occasionally one may see
severe distal colitis with dilatation of the
proximal normal colon but the haustrations
are normal and the mucosa is smooth. The
diagnosis of toxic megacolon requires a
dilated colon and an irregular mucosal sur
face, particularly one with the filling defects
that Professor Brooke has called “mucosal
islands”. Any part of the colon may become
dilated, although the transverse colon is the
most common site. When I see these signs
I do not regard the situation as a medical
problem but, rather, as a surgical emergency.
We confine our treatment purely to resus
citation, and our surgical colleagues will
undertake an operation as soon as the pa
tient is fit to withstand it. I have seen Mr.
O. V. Lloyd-Davies of St. Mark’s Hospital,
London, operating on patients with toxic
megacolon and he has a trick which I have

456

THE CANADIAN JOURNAL OF SURGERY

always thought to be useful for decompress
ing the dilated colon. After he has opened
the abdomen, an assistant passes a rubber
tube up through the anus and the surgeon
decompresses the colon by manipulating
the tube around the colon from within the
abdomen. This leaves the surgeon with an
empty and flaccid colon to deal with. Toxic
megacolon has a high mortality and our
aim must be to prevent it from developing.
We have not had a toxic megacolon at St.
Mark’s Hospital for quite some time now
and I think Mr. de Dombal has hinted that
they also are seeing it much less often.
D r . D evroede: I think Mr. de Dombal
stated earlier that 80% of the patients who
have had proctocolectomy do not have ma
jor inconvenience. Could you comment
about impotence in the male patient after
proctocolectomy?
Mr . de D ombal : I am glad that you have
raised this point as this is another reason
why we tend to operate on people with total
involvement of the colon relatively early.
There is a small but definite incidence of
impotence in the male after proctocolectomy
and, in our experience, it is related to the
age of the patient. We have found in Leeds
that the rate of long-term postoperative
sexual complications, that is to say infer
tility, failure of ejaculation and impotence,
in men under the age of 40 is less than 3 %.
After 40 the risk becomes much higher. It
is not possible to say without control studies
whether this is an anatomical defect, or is
something related to a lack of sexual interest
on the part of the patient after his operation.
We have tried to answer this question and
we cannot.
D r . D evroede : I suspect that in many pa
tients the impotence that develops has
nothing to do with their operation but is
psychogenic.
Mr . de D ombal : We have found that the
majority of the early problems do clear up
in the immediate few months after surgery,
especially in men under the age of 40. Our
patients find this piece of news extremely
reassuring.
D r . L ennard-J ones: Among the members
of the British Ileostomy Association there
is great concern about this problem. They
have asked Professor Brooke and me to
help them investigate it and within a year
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or two we hope to have some data on the
subject. I think that we are dealing with a
largely hidden difficulty which, with the
increasing freedom in discussion of sexual
matters, is coming into the open.
M ember of the A udience : Could some
one comment on the use of immunosuppres
sive agents in Crohn’s disease and ulcerative
colitis?
D r . L ennard-J ones : The information in
ulcerative colitis is meagre at the moment.
There has been, to my knowledge, only one
controlled trial and this trial, by Dr. Truelove and his collaborators in Oxford, gave
equivocal results, with a slight bias towards
azathioprine. We are awaiting the publica
tion of the second half of their report which
should be available quite soon. In Crohn’s
disease, as I have already mentioned, there
has been one trial with a positive result and
one with a negative result.
D r . Spencer : In the United States there is
currently a multi-institutional, double-blind,
prospective study going on of the use of
cortisone and azathioprine in the treatment
of both ulcerative colitis and Crohn’s dis
ease. I expect the preliminary results to be
available in approximately 18 months.
M ember of the A udience : Could the
British members of the panel comment on
the use of ileorectal anastomosis advocated
by Mr. Aylett of Britain?
M r . de D ombal : I have seen Mr. Aylett’s
patients and I am the first to admit, coming
from a centre that does a different operation,
that about 30% of his patients have very
good results. There are another 30% to
40% who have about four or five bowel
motions a day and these seem to be getting
along reasonably well. But the remainder of
the patients have more bowel movements
a day— up to eight or 10 in some cases—
and in these I would consider the results of
the operation unsatisfactory. I think what
needs to be done in terms of the short-term
prognosis is to find out why an ileorectal
anastomosis works for some patients and not
for others. Perhaps we could find a reliable
prognostic index that would enable us to
select the 30% of our patients for ileorectal
anastomosis so that proctocolectomy can be
performed for the remaining 70%. There
may be a very real cancer risk following ab
dominal colectomy but this is a long-term
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problem and we do not have accurate data an ileostomy. The difference is not great
available.
but quite significant. It looks as though
D r . L ennard -J o n e s : We have been very
most patients do well if the effluent from
interested in this problem at St. Mark’s Hos their ileum is small, in the same way that
pital. Some of my colleagues interviewed a some patients have a liquid ileostomy ef
group of Mr. ^ ylett’s patients and a group fluent and other have a semisolid ileostomy
of our own patients who have been treated output. I know some surgeons who will not
by colectomy and ileorectal anastomosis. I convert an ileostomy to an ileorectal anas
cannot remember the figures exactly but I tomosis if the effluent from the ileostomy is
think that about 25% of the patients had liquid. On the other hand, if it is semisolid
fewer than three bowel movements a day. and, let us say, 300 g a day, they feel that
Most patients have between three and six the patient may do well with an ileorectal
bowel actions a day and there was a group anastomosis. The outcome of this operation
with more than six. There were some other correlates rather poorly with the degree of
interesting observations. Quite a high pro inflammation found in the rectum. There
portion of the patients had one bowel action is an increased cancer risk in the rectum that
during the night and about 5 % had urgency is difficult to assess at the present time.
of defecation. I would agree with Mr. de These patients must be followed up indefi
Dombal that about 50% of the patients nitely with sigmoidoscopic examinations and
with ileorectal anastomosis have a good re multiple biopsies. I think ileorectal anasto
sult. You may be interested to know that mosis is a useful operation in young patients
approximately 20% of patients treated as it may tide them over a critical period
surgically for ulcerative colitis at our hos in their lives. But one must explain to the
pital undergo colectomy and ileorectal patient beforehand that this operation may
anastomosis. At the present time we do not or may not be successful, that they will
have a prognostic index. It has been shown have to be followed up indefinitely, and that
that a patient with an ileorectal anastomosis they may have to have an ileostomy at a
loses less water and salt than a patient with later date.
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ERRATUM: In the September issue of the
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nolol: etude de 15 observations”. We offer
our apologies to Dr. Fortin and to our
readers for this oversight.

